FF:10497-107C2: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{f5samples
|id=FF:10497-107C2
|name=endometrial carcinoma cell line:OMC-2, biol_rep1
|sample_id=10497
|rna_tube_id=107C2
|rna_box=107
|rna_position=C2
|sample_cell_lot...") |
No edit summary |
||
(29 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
| | |DRA_sample_Accession=CAGE@SAMD00005280 | ||
| | |accession_numbers=CAGE;DRX007876;DRR008748;DRZ000173;DRZ001558;DRZ011523;DRZ012908 | ||
| | |ancestors_in_anatomy_facet=UBERON:0000468,UBERON:0000995,UBERON:0002384,UBERON:0003134,UBERON:0000479,UBERON:0005156,UBERON:0000062,UBERON:0004120,UBERON:0000061,UBERON:0000465,UBERON:0000990,UBERON:0000467,UBERON:0001062,UBERON:0000480,UBERON:0003133,UBERON:0003975,UBERON:0004175,UBERON:0010317,UBERON:0003100,UBERON:0000474 | ||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000548,CL:0002320,CL:0000066,CL:0002371,CL:0000499,CL:0000255,CL:0002076,CL:0002149,CL:0002255 | |||
|ancestors_in_disease_facet=DOID:4,DOID:0050686,DOID:162,DOID:14566,DOID:0050687,DOID:193,DOID:305,DOID:120,DOID:299,DOID:3001 | |||
|ancestors_in_ff_facet=FF:0000102,FF:0000003,FF:0000210,FF:0000101,FF:0000001,FF:0100297,FF:0101120,FF:0100167,FF:0101555 | |||
|comment= | |||
|created_by= | |||
|creation_date= | |||
|data_phase=2 | |||
|datafreeze_phase=2 | |||
|def= | |||
|expression_enrichment_score=chr12:66218255..66218304,+!p3@HMGA2!2.18!389.35!HMGA2;;chr2:114036488..114036504,-!p1@PAX8!1.99!96.77!PAX8;;chr2:105470562..105470582,+!p@chr2:105470562..105470582,+!1.82!65.18!POU3F3;;chr17:46675558..46675577,-!p2@HOXB6!1.80!62.33!HOXB6;;chr17:48072574..48072597,-!p1@DLX3!1.76!56.35!DLX3;;chr1:201979743..201979762,+!p1@ELF3!1.74!54.36!ELF3;;chr6:10415484..10415508,-!p3@TFAP2A!1.72!51.23!TFAP2A;;chr11:34642612..34642646,+!p1@EHF!1.68!46.68!EHF;;chr7:27192185..27192209,-!p1@HOXA3!1.64!42.41!HOXA3;;chr7:27205136..27205164,-!p1@HOXA9!1.62!40.98!HOXA9;;chr12:66218212..66218244,+!p5@HMGA2!1.60!55.50!HMGA2;;chr7:27205106..27205134,-!p2@HOXA9!1.60!38.99!HOXA9;;chr17:46622205..46622218,-!p3@HOXB2!1.58!42.12!HOXB2;;chr17:36105042..36105060,-!p1@HNF1B!1.57!36.15!HNF1B;;chr12:66218378..66218401,+!p6@HMGA2!1.56!53.51!HMGA2;;chr12:26277956..26277980,-!p1@BHLHE41!1.55!118.97!BHLHE41;;chr12:26277817..26277863,-!p2@BHLHE41!1.55!45.82!BHLHE41;;chr6:126240442..126240459,+!p4@NCOA7!1.55!43.26!NCOA7;;chr7:27153454..27153469,-!p2@HOXA3!1.54!33.87!HOXA3;;chr12:66218183..66218209,+!p4@HMGA2!1.51!58.91!HMGA2;;chr17:46703687..46703740,-!p1@HOXB9!1.45!27.32!HOXB9;;chr12:66218836..66218888,+!p1@HMGA2!1.44!237.36!HMGA2;;chr12:66218443..66218461,+!p8@HMGA2!1.41!31.31!HMGA2;;chr6:10415276..10415341,-!p2@TFAP2A!1.37!27.61!TFAP2A;;chr7:27196217..27196246,-!p2@HOXA7!1.37!22.48!HOXA7;;chr3:12330560..12330579,+!p1@PPARG!1.36!25.05!PPARG;;chr1:201979703..201979721,+!p2@ELF3!1.35!21.35!ELF3;;chr17:46667594..46667619,-!p1@HOXB3!1.34!21.06!HOXB3;;chrX:2418949..2419024,-!p1@DHRSX,p1@ZBED1!1.34!20.78!ZBED1;;chr6:126240380..126240430,+!p2@NCOA7!1.33!51.51!NCOA7;;chr6:10412600..10412637,-!p1@TFAP2A!1.33!33.58!TFAP2A;;chr12:26278008..26278024,-!p4@BHLHE41!1.33!24.48!BHLHE41;;chr7:63505799..63505904,+!p1@ZNF727!1.33!20.49!ZNF727;;chr12:27485785..27485816,+!p1@ARNTL2!1.31!130.64!ARNTL2;;chr18:55102628..55102646,+!p2@ONECUT2!1.31!19.64!ONECUT2;;chr12:66218420..66218439,+!p12@HMGA2!1.31!19.35!HMGA2;;chr9:100615499..100615519,+!p1@FOXE1!1.31!19.35!FOXE1;;chr12:66218598..66218645,+!p2@HMGA2!1.28!82.54!HMGA2;;chr12:26278030..26278039,-!p7@BHLHE41!1.26!17.08!BHLHE41;;chr6:19837592..19837621,+!p1@ID4!1.24!99.33!ID4;;chr2:46524897..46524911,+!p2@EPAS1!1.24!44.97!EPAS1;;chr2:105470536..105470556,+!p@chr2:105470536..105470556,+!1.21!15.37!POU3F3;;chr14:29234581..29234601,+!p2@FOXG1!1.21!15.37!FOXG1;;chr7:113726357..113726443,+!p1@FOXP2!1.19!25.05!FOXP2;;chr7:28610099..28610113,+!p5@CREB5!1.18!14.23!CREB5;;chr18:55102598..55102623,+!p1@ONECUT2!1.18!14.23!ONECUT2;;chr13:100634031..100634045,+!p1@ZIC2!1.17!13.66!ZIC2;;chr7:26191809..26191890,+!p1@NFE2L3!1.16!66.03!NFE2L3;;chr8:77593474..77593612,+!p1@ZFHX4!1.16!57.21!ZFHX4;;chr12:27485762..27485776,+!p3@ARNTL2!1.16!36.15!ARNTL2;;chr17:46688334..46688385,-!p1@HOXB7!1.16!19.35!HOXB7;;chr19:53496768..53496799,-!p1@ZNF702P!1.15!20.49!ZNF702P;;chr7:57509877..57509895,+!p1@ZNF716!1.15!13.09!ZNF716;;chr12:26277929..26277955,-!p3@BHLHE41!1.13!17.93!BHLHE41;;chr6:126240463..126240489,+!p6@NCOA7!1.13!13.95!NCOA7;;chr3:141747459..141747475,-!p1@TFDP2!1.11!99.61!TFDP2;;chr12:66357214..66357233,+!p13@HMGA2!1.11!11.95!HMGA2;;chr17:46675619..46675642,-!p5@HOXB6!1.11!11.95!HOXB6;;chr17:41622765..41622821,-!p2@ETV4!1.10!17.65!ETV4;;chr17:46622229..46622257,-!p6@HOXB2!1.10!13.66!HOXB2;;chr3:169381420..169381535,-!p1@MECOM!1.09!13.38!MECOM;;chr17:46622440..46622477,-!p5@HOXB2!1.09!12.81!HOXB2;;chr8:102504651..102504683,+!p1@GRHL2!1.09!11.38!GRHL2;;chr5:137804405..137804444,+!p3@EGR1!1.08!13.38!EGR1;;chr8:55370487..55370503,+!p1@SOX17!1.08!11.10!SOX17;;chr12:66218003..66218018,+!p9@HMGA2!1.07!13.09!HMGA2;;chr6:28321909..28321965,-!p3@ZNF323!1.07!10.82!ZNF323;;chr19:53758058..53758088,-!p2@ZNF677!1.05!33.87!ZNF677;;chr13:100623375..100623425,-!p1@ZIC5!1.05!10.25!ZIC5;;chr2:200322654..200322707,-!p2@SATB2!1.04!14.52!SATB2;;chr4:149363475..149363492,-!p2@NR3C2!1.04!9.96!NR3C2;;chr12:66218152..66218174,+!p10@HMGA2!1.03!10.53!HMGA2;;chr14:29235961..29236008,+!p1@FOXG1!1.03!9.68!FOXG1;;chr3:69915385..69915438,+!p3@MITF!1.03!9.68!MITF;;chr4:149363494..149363543,-!p1@NR3C2!1.03!9.68!NR3C2;;chr17:46671108..46671147,-!p1@HOXB5!1.03!9.68!HOXB5;;chr16:51185172..51185197,-!p1@SALL1!1.02!9.39!SALL1;;chr17:41622731..41622764,-!p5@ETV4!1.02!9.39!ETV4;;chr6:10419768..10419819,-!p6@TFAP2A!1.02!9.39!TFAP2A;;chr12:27485823..27485868,+!p2@ARNTL2!1.01!37.85!ARNTL2;;chr17:41623009..41623053,-!p4@ETV4!1.01!15.08!ETV4;;chr9:4300050..4300118,-!p1@GLIS3!1.00!59.48!GLIS3;;chr7:28448965..28448994,+!p2@CREB5!1.00!32.16!CREB5;;chr3:69788576..69788648,+!p1@MITF!0.99!48.10!MITF;;chr2:60780753..60780800,-!p1@BCL11A!0.99!43.83!BCL11A;;chr19:49864746..49864780,-!p2@TEAD2!0.97!11.67!TEAD2;;chr12:26277994..26278001,-!p6@BHLHE41!0.97!8.25!BHLHE41;;chr8:116681409..116681431,-!p2@TRPS1!0.96!23.05!TRPS1;;chr12:54447599..54447630,+!p3@HOXC4!0.95!9.68!HOXC4;;chr14:29236269..29236285,+!p3@FOXG1!0.95!7.97!FOXG1;;chr3:114343826..114343869,-!p4@ZBTB20!0.94!15.65!ZBTB20;;chr11:34642656..34642667,+!p2@EHF!0.94!7.68!EHF;;chr13:100634130..100634143,+!p3@ZIC2!0.94!7.68!ZIC2;;chr19:12348371..12348386,-!p5@ZNF44!0.94!7.68!ZNF44;;chr7:6655225..6655279,+!p1@ENST00000457543!0.93!11.38!ZNF853;;chr1:247171316..247171336,-!p3@ZNF695!0.93!11.38!ZNF695;;chr19:50169013..50169062,-!p2@IRF3!0.92!44.40!IRF3;;chr3:12329358..12329393,+!p3@PPARG!0.92!18.78!PPARG;;chr19:52391220..52391251,-!p2@ZNF577!0.92!10.53!ZNF577;;chr2:25475120..25475176,-!p2@DNMT3A!0.92!9.96!DNMT3A;;chr1:209979467..209979494,-!p1@IRF6!0.91!7.97!IRF6;;chr4:111544219..111544240,-!p1@PITX2!0.91!7.12!PITX2;;chr7:73038839..73038862,-!p1@MLXIPL!0.91!7.12!MLXIPL;;chr1:151804244..151804310,-!p1@RORC!0.89!6.83!RORC;;chr2:191878874..191878938,-!p1@STAT1!0.88!376.54!STAT1;;chr12:66218573..66218596,+!p7@HMGA2!0.88!9.96!HMGA2;;chr12:66218904..66218913,+!p11@HMGA2!0.88!6.55!HMGA2;;chr3:114343870..114343887,-!p9@ZBTB20!0.88!6.55!ZBTB20;;chr7:27213893..27213954,-!p1@HOXA10!0.88!6.55!HOXA10;;chr7:27219833..27219845,-!p7@HOXA10!0.88!6.55!HOXA10;;chr17:41622925..41622976,-!p3@ETV4!0.87!9.96!ETV4;;chr15:80696703..80696754,+!p1@ARNT2!0.87!8.82!ARNT2;;chr3:101568349..101568365,+!p1@NFKBIZ!0.86!347.51!NFKBIZ;;chr5:137804357..137804390,+!p4@EGR1!0.86!7.40!EGR1;;chr6:10419824..10419840,-!p9@TFAP2A!0.86!6.26!TFAP2A;;chr3:69915369..69915381,+!p4@MITF!0.86!6.26!MITF;;chr19:46800289..46800327,+!p2@HIF3A!0.86!6.26!HIF3A;;chr12:80084737..80084763,-!p3@PAWR!0.85!24.19!PAWR;;chr19:52408227..52408243,-!p2@ZNF649!0.85!14.23!ZNF649;;chr2:60780607..60780624,-!p2@BCL11A!0.84!19.07!BCL11A;;chr11:65554528..65554546,+!p1@OVOL1!0.84!5.98!OVOL1;;chr12:26277798..26277809,-!p5@BHLHE41!0.84!5.98!BHLHE41;;chr9:20621834..20621884,-!p5@MLLT3!0.84!5.98!MLLT3;;chr17:46692457..46692484,-!p2@HOXB8!0.84!5.98!HOXB8;;chr7:27196196..27196210,-!p5@HOXA7!0.84!5.98!HOXA7;;chr19:22817119..22817145,+!p1@ZNF492!0.83!9.96!ZNF492;;chr12:54785074..54785122,-!p2@ZNF385A!0.83!9.11!ZNF385A;;chr3:170076314..170076334,+!p2@SKIL!0.83!7.68!SKIL;;chr12:26276197..26276214,-!p8@BHLHE41!0.83!5.69!BHLHE41;;chr17:46622175..46622186,-!p12@HOXB2!0.83!5.69!HOXB2;;chr17:46667561..46667572,-!p4@HOXB3!0.83!5.69!HOXB3;;chr17:46675469..46675481,-!p4@HOXB6!0.83!5.69!HOXB6;;chr7:64126503..64126528,+!p1@ZNF107!0.82!42.41!ZNF107;;chr17:41623692..41623715,-!p1@ETV4!0.82!25.33!ETV4;;chr19:20188776..20188826,+!p1@ZNF90!0.82!15.94!ZNF90;;chr17:46655704..46655718,-!p2@HOXB4!0.82!8.54!HOXB4;;chr3:141747441..141747452,-!p4@TFDP2!0.82!7.97!TFDP2;;chr6:10412392..10412409,-!p4@TFAP2A!0.82!6.55!TFAP2A;;chr19:52408257..52408278,-!p1@ZNF649!0.81!38.42!ZNF649;;chr21:44441260..44441273,+!p3@PKNOX1!0.81!5.41!PKNOX1;;chr3:101575889..101575903,+!p3@NFKBIZ!0.81!5.41!NFKBIZ;;chr5:124082322..124082364,-!p1@ZNF608!0.80!14.52!ZNF608;;chr2:200323414..200323455,-!p1@SATB2!0.80!11.95!SATB2;;chr3:101546827..101546847,+!p2@NFKBIZ!0.80!7.68!NFKBIZ;;chr17:46675420..46675465,-!p3@HOXB6!0.80!6.26!HOXB6;;chr19:36706055..36706074,+!p3@ZNF146!0.79!26.18!ZNF146;;chr14:21994337..21994442,-!p1@SALL2!0.79!15.08!SALL2;;chr12:66218469..66218477,+!p16@HMGA2!0.79!5.12!HMGA2;;chr6:28321971..28321995,-!p1@ZNF323!0.79!5.12!ZNF323;;chr8:102504690..102504704,+!p3@GRHL2!0.79!5.12!GRHL2;;chr9:14314131..14314147,-!p2@NFIB!0.78!30.17!NFIB;;chr19:53636125..53636178,-!p1@ZNF415!0.78!15.37!ZNF415;;chr16:30537839..30537929,-!p1@ZNF768!0.77!33.87!ZNF768;;chr19:2867325..2867348,+!p1@ZNF556!0.77!4.84!ZNF556;;chr2:25475094..25475112,-!p3@DNMT3A!0.77!4.84!DNMT3A;;chr3:168865250..168865272,-!p5@MECOM!0.77!4.84!MECOM;;chr19:45971246..45971265,+!p1@FOSB!0.76!97.34!FOSB;;chr19:52391147..52391218,-!p1@ZNF577!0.76!16.22!ZNF577;;chr7:27135591..27135658,-!p1@HOXA1!0.76!9.68!HOXA1;;chr19:33865009..33865090,+!p3@CEBPG!0.76!6.55!CEBPG;;chr7:102985160..102985273,-!p1@DNAJC2!0.75!127.22!DNAJC2;;chr13:73633131..73633149,+!p1@KLF5!0.75!55.21!KLF5;;chr19:52901094..52901134,+!p1@ZNF528!0.75!34.15!ZNF528;;chr17:41277372..41277418,-!p1@BRCA1!0.75!18.22!BRCA1;;chr10:104155659..104155676,+!p4@NFKB2!0.75!5.98!NFKB2;;chr2:191878812..191878823,-!p2@STAT1!0.75!5.98!STAT1;;chr5:124082279..124082319,-!p3@ZNF608!0.75!5.69!ZNF608;;chr19:22235279..22235301,+!p1@ZNF257!0.74!9.11!ZNF257;;chr20:50721803..50721857,-!p2@ZFP64!0.74!7.40!ZFP64;;chr15:67458491..67458505,+!p18@SMAD3!0.74!4.55!SMAD3;;chr17:46688310..46688323,-!p4@HOXB7!0.74!4.55!HOXB7;;chr17:46692318..46692362,-!p5@HOXB8!0.74!4.55!HOXB8;;chr17:46703826..46703845,-!p3@HOXB9!0.74!4.55!HOXB9;;chr17:74137321..74137337,-!p1@FOXJ1!0.74!4.55!FOXJ1;;chr19:37464453..37464515,+!p4@ZNF568!0.74!4.55!ZNF568;;chr7:101917407..101917443,+!p3@CUX1!0.74!4.55!CUX1;;chr7:27196267..27196311,-!p1@HOXA7!0.74!4.55!HOXA7;;chr8:76319876..76319926,+!p1@HNF4G!0.74!4.55!HNF4G;;chr11:65554563..65554576,+!p2@OVOL1!0.74!4.55!OVOL1;;chr14:37051798..37051831,-!p1@NKX2-8!0.74!4.55!NKX2-8;;chr4:87927888..87927912,+!p18@AFF1!0.74!4.55!AFF1;;chr2:231084639..231084654,-!p2@SP110!0.73!7.68!SP110;;chr19:53400852..53400962,-!p1@ZNF320!0.72!47.53!ZNF320;;chr7:28725740..28725778,+!p1@CREB5!0.72!42.41!CREB5;;chr7:27153428..27153440,-!p3@HOXA3!0.72!4.27!HOXA3;;chr7:35293685..35293718,-!p1@TBX20!0.72!4.27!TBX20;;chr19:47538560..47538591,+!p2@NPAS1!0.72!4.27!NPAS1;;chr21:38071430..38071456,+!p1@SIM2!0.72!4.27!SIM2;;chr2:122042770..122042785,-!p1@TFCP2L1!0.72!4.27!TFCP2L1;;chr17:46690839..46690884,-!p1@HOXB8!0.72!4.27!HOXB8;;chr12:66218413..66218418,+!p17@HMGA2!0.72!4.27!HMGA2;;chr19:54024251..54024305,+!p4@ZNF331!0.71!7.12!ZNF331;;chr16:4366053..4366076,+!p@chr16:4366053..4366076,+!0.70!45.82!GLIS2;;chr15:67458861..67458879,+!p17@SMAD3!0.70!3.98!SMAD3;;chr17:46703528..46703549,-!p5@HOXB9!0.70!3.98!HOXB9;;chr19:19281060..19281078,-!p2@MEF2BNB-MEF2B,p2@MEF2B!0.70!3.98!MEF2B;;chr12:66358080..66358094,+!p15@HMGA2!0.70!3.98!HMGA2;;chr7:113726226..113726245,+!p3@FOXP2!0.70!3.98!FOXP2;;chr19:58545454..58545498,+!p1@ZSCAN1!0.70!3.98!ZSCAN1;;chr19:23433144..23433204,-!p1@ZNF724P!0.69!19.64!ZNF724P;;chr10:44070016..44070069,-!p1@ZNF239!0.69!12.81!ZNF239;;chr17:46622070..46622109,-!p1@HOXB2!0.69!9.39!HOXB2;;chr17:41622834..41622883,-!p6@ETV4!0.69!4.84!ETV4;;chr19:58400372..58400411,-!p1@ZNF814!0.68!22.20!ZNF814;;chr10:64576105..64576133,-!p1@EGR2!0.67!8.25!EGR2;;chr17:46622114..46622138,-!p4@HOXB2!0.67!5.98!HOXB2;;chr17:46667628..46667642,-!p2@HOXB3!0.67!3.70!HOXB3;;chr19:22605136..22605154,-!p1@ZNF98!0.67!3.70!ZNF98;;chr19:57352087..57352102,-!p1@PEG3,p1@ZIM2!0.67!3.70!PEG3;;chr3:181429741..181429767,+!p2@SOX2!0.67!3.70!SOX2;;chr7:27170359..27170381,-!p1@HOXA4!0.67!3.70!HOXA4;;chr19:37064145..37064216,-!p1@ZNF529!0.66!35.01!ZNF529;;chrX:129402866..129402880,-!p1@ZNF280C!0.66!23.34!ZNF280C;;chr16:30546141..30546240,-!p1@ZNF747,p2@ZNF768!0.66!16.22!ZNF747;;chr7:102985288..102985310,-!p2@DNAJC2!0.66!9.39!DNAJC2;;chr17:46687959..46688007,-!p2@HOXB7!0.66!5.12!HOXB7;;chr19:52839490..52839508,+!p2@ZNF610!0.66!4.55!ZNF610;;chr3:185826855..185826911,-!p1@ETV5!0.65!111.28!ETV5;;chr20:62462566..62462631,-!p1@ZBTB46!0.65!7.12!ZBTB46;;chr1:247171347..247171366,-!p2@ZNF695!0.65!6.83!ZNF695;;chr2:46524878..46524891,+!p3@EPAS1!0.65!6.55!EPAS1;;chr9:20621927..20621996,-!p3@MLLT3!0.65!6.26!MLLT3;;chr12:54785054..54785072,-!p4@ZNF385A!0.65!3.98!ZNF385A;;chr5:137801160..137801176,+!p1@EGR1!0.64!401.01!EGR1;;chr19:37663572..37663630,-!p1@ZNF585A!0.64!46.39!ZNF585A;;chr5:137804484..137804498,+!p2@EGR1!0.64!15.65!EGR1;;chr19:37997812..37997866,+!p1@ZNF793!0.64!6.26!ZNF793;;chrX:84498989..84499003,+!p1@ZNF711!0.64!4.84!ZNF711;;chrX:131547625..131547644,-!p4@MBNL3!0.64!3.42!MBNL3;;chr15:80696410..80696477,+!p6@ARNT2!0.64!3.42!ARNT2;;chr17:46675539..46675551,-!p7@HOXB6!0.64!3.42!HOXB6;;chr12:66357317..66357328,+!p19@HMGA2!0.64!3.42!HMGA2;;chr13:100638100..100638115,+!p4@ZIC2!0.64!3.42!ZIC2;;chr6:10412576..10412599,-!p5@TFAP2A!0.64!3.42!TFAP2A;;chr6:10415263..10415274,-!p8@TFAP2A!0.64!3.42!TFAP2A;;chr6:126240542..126240553,+!p14@NCOA7!0.64!3.42!NCOA7;;chr6:28048343..28048354,+!p1@ZNF165!0.64!3.42!ZNF165;;chr7:27153613..27153630,-!p6@HOXA3!0.64!3.42!HOXA3;;chr2:180427261..180427297,-!p6@ZNF385B!0.64!3.42!ZNF385B;;chr3:125093970..125093986,-!p5@ZNF148!0.64!3.42!ZNF148;;chr19:36706024..36706049,+!p1@ZNF146!0.63!69.44!ZNF146;;chr16:30798492..30798535,-!p1@ZNF629!0.63!61.19!ZNF629;;chr3:141868293..141868355,-!p2@TFDP2!0.63!33.58!TFDP2;;chr12:80084303..80084332,-!p1@PAWR!0.63!22.77!PAWR;;chr16:30406721..30406820,+!p1@ZNF48!0.63!21.06!ZNF48;;chr1:8763440..8763460,-!p2@RERE!0.63!19.07!RERE;;chr19:44952635..44952668,-!p1@ZNF229!0.63!18.78!ZNF229;;chr19:53289995..53290050,-!p1@ZNF600!0.63!15.65!ZNF600;;chr4:87928142..87928165,+!p5@AFF1!0.63!12.81!AFF1;;chr12:51566562..51566584,-!p2@TFCP2!0.63!10.53!TFCP2;;chr1:23696308..23696339,-!p2@ZNF436!0.63!7.68!ZNF436;;chr19:56988677..56988729,-!p1@ZNF667!0.63!6.26!ZNF667;;chr19:37997297..37997362,+!p3@ZNF793!0.63!5.69!ZNF793;;chr19:33864600..33864732,+!p1@CEBPG!0.62!107.01!CEBPG;;chr3:141868357..141868393,-!p3@TFDP2!0.62!24.76!TFDP2;;chr16:4366021..4366045,+!p@chr16:4366021..4366045,+!0.62!17.93!GLIS2;;chr10:97889464..97889494,+!p3@ZNF518A!0.62!6.55!ZNF518A;;chr6:85474299..85474324,-!p1@TBX18!0.62!6.26!TBX18;;chr19:49139477..49139552,-!p4@DBP!0.62!4.27!DBP;;chr19:58383174..58383178,-!p3@ZNF814!0.62!3.70!ZNF814;;chr12:27485733..27485742,+!p5@ARNTL2!0.62!3.70!ARNTL2;;chr12:54447637..54447659,+!p4@HOXC4!0.62!3.13!HOXC4;;chr14:29236169..29236216,+!p6@FOXG1!0.62!3.13!FOXG1;;chr14:38064429..38064486,-!p1@FOXA1!0.62!3.13!FOXA1;;chr4:188916918..188916942,+!p1@ZFP42!0.62!3.13!ZFP42;;chr19:58545369..58545404,+!p2@ZSCAN1!0.62!3.13!ZSCAN1;;chr1:24645921..24645973,+!p2@GRHL3!0.62!3.13!GRHL3;;chr5:124081979..124082021,-!p7@ZNF608!0.62!3.13!ZNF608;;chr7:27213872..27213886,-!p4@HOXA10!0.62!3.13!HOXA10;;chr7:57509910..57509917,+!p2@ZNF716!0.62!3.13!ZNF716;;chr8:77593750..77593757,+!p3@ZFHX4!0.62!3.13!ZFHX4;;chr10:77161504..77161530,-!p1@ZNF503!0.61!48.95!ZNF503;;chr19:35168567..35168620,+!p1@ZNF302!0.61!42.98!ZNF302;;chr6:34205372..34205412,+!p5@HMGA1!0.61!18.50!HMGA1;;chr9:20622444..20622468,-!p2@MLLT3!0.61!11.38!MLLT3;;chr18:3451646..3451691,+!p3@TGIF1!0.61!9.39!TGIF1;;chr19:52839515..52839572,+!p1@ZNF610!0.61!7.40!ZNF610;;chr19:53073532..53073551,+!p1@ZNF701!0.60!15.94!ZNF701;;chr3:114343768..114343822,-!p1@ZBTB20!0.60!15.37!ZBTB20;;chr19:21265028..21265052,+!p2@ZNF714!0.60!5.98!ZNF714;;chr3:42947600..42947680,+!p1@ZNF662!0.60!4.55!ZNF662;;chr6:28973090..28973094,-!p1@ZNF311!0.60!3.98!ZNF311;;chr2:60778035..60778060,-!p4@BCL11A!0.60!3.70!BCL11A;;chr19:53360870..53360873,-!p1@ZNF468!0.59!12.52!ZNF468;;chr19:40596789..40596825,-!p2@ZNF780A!0.59!10.25!ZNF780A;;chr15:41913690..41913753,+!p2@MGA!0.59!7.97!MGA;;chr3:185826814..185826825,-!p3@ETV5!0.59!5.98!ETV5;;chrX:84499081..84499115,+!p2@ZNF711!0.59!4.55!ZNF711;;chr11:6947720..6947812,+!p1@ZNF215!0.59!3.98!ZNF215;;chr2:231084820..231084836,-!p5@SP110!0.59!3.42!SP110;;chr2:177001290..177001315,+!p1@HOXD3!0.59!2.85!HOXD3;;chr5:124082470..124082483,-!p8@ZNF608!0.59!2.85!ZNF608;;chr7:28610060..28610073,+!p9@CREB5!0.59!2.85!CREB5;;chr7:96634850..96634874,+!p3@DLX6!0.59!2.85!DLX6;;chr9:22447422..22447483,+!p1@DMRTA1!0.59!2.85!DMRTA1;;chr17:36104873..36104903,-!p3@HNF1B!0.59!2.85!HNF1B;;chr17:41622982..41623001,-!p11@ETV4!0.59!2.85!ETV4;;chr17:46703942..46703964,-!p4@HOXB9!0.59!2.85!HOXB9;;chr21:38071403..38071428,+!p2@SIM2!0.59!2.85!SIM2;;chr10:60145155..60145206,+!p1@TFAM!0.58!150.84!TFAM;;chr7:139762641..139762768,-!p1@PARP12!0.58!46.68!PARP12;;chr2:239148671..239148686,-!p1@HES6!0.58!12.24!HES6;;chr11:61520075..61520136,+!p1@C11orf9!0.58!6.83!C11orf9;;chr16:31724618..31724630,+!p2@ZNF720!0.58!5.98!ZNF720;;chr3:40547564..40547616,+!p1@ZNF620!0.58!4.27!ZNF620;;chr12:80083807..80083859,-!p11@PAWR!0.58!3.70!PAWR;;chr2:46524537..46524553,+!p1@EPAS1!0.57!338.40!EPAS1;;chr19:45908292..45908374,-!p1@PPP1R13L!0.57!29.88!PPP1R13L;;chr12:80084768..80084821,-!p2@PAWR!0.57!22.77!PAWR;;chr5:138609782..138609826,+!p5@MATR3!0.57!21.35!MATR3;;chr1:61547894..61547968,+!p2@NFIA!0.57!9.39!NFIA;;chr19:33864571..33864596,+!p2@CEBPG!0.57!7.68!CEBPG;;chr3:12329397..12329433,+!p2@PPARG!0.57!7.12!PPARG;;chr16:31885093..31885165,+!p1@ZNF267!0.56!50.38!ZNF267;;chr1:246729483..246729538,-!p2@TFB2M!0.56!31.02!TFB2M;;chr19:23941680..23941704,-!p1@ZNF681!0.56!9.11!ZNF681;;chr1:161736038..161736056,+!p4@ATF6!0.56!7.12!ATF6;;chr3:107244229..107244254,+!p3@BBX!0.56!4.84!BBX;;chr6:21597600..21597664,+!p3@SOX4!0.56!4.84!SOX4;;chr4:87928105..87928126,+!p13@AFF1!0.56!4.27!AFF1;;chr7:28448995..28449011,+!p4@CREB5!0.56!3.98!CREB5;;chr19:52408285..52408310,-!p3@ZNF649!0.55!7.12!ZNF649;;chr19:52430697..52430749,+!p1@ZNF613!0.55!7.12!ZNF613;;chr5:76383133..76383186,-!p2@ZBED3!0.55!5.98!ZBED3;;chr7:101917447..101917479,+!p4@CUX1!0.55!2.56!CUX1;;chr7:137620684..137620711,-!p4@CREB3L2!0.55!2.56!CREB3L2;;chr7:27219849..27219867,-!p6@HOXA10!0.55!2.56!HOXA10;;chr13:100634004..100634025,+!p2@ZIC2!0.55!2.56!ZIC2;;chr17:40180680..40180726,-!p1@ZNF385C!0.55!2.56!ZNF385C;;chr17:46128217..46128243,+!p11@NFE2L1!0.55!2.56!NFE2L1;;chr17:46675586..46675600,-!p6@HOXB6!0.55!2.56!HOXB6;;chr2:105470599..105470610,+!p@chr2:105470599..105470610,+!0.55!2.56!POU3F3;;chr2:113982635..113982648,-!p8@PAX8!0.55!2.56!PAX8;;chr2:37458692..37458745,-!p1@CEBPZ!0.54!118.68!CEBPZ;;chr3:107241792..107241845,+!p1@BBX!0.54!70.87!BBX;;chr19:57791328..57791377,+!p2@ZNF460!0.54!37.85!ZNF460;;chr19:52490043..52490113,-!p1@ZNF350!0.54!24.19!ZNF350;;chr20:47894936..47895010,-!p2@ZNFX1!0.54!9.68!ZNFX1;;chr19:36705617..36705644,+!p4@ZNF146!0.54!8.54!ZNF146;;chr14:74353454..74353469,+!p4@ZNF410!0.54!5.41!ZNF410;;chr3:40566488..40566502,+!p3@ZNF621!0.54!5.12!ZNF621;;chr4:87857474..87857489,+!p7@AFF1!0.54!4.84!AFF1;;chr19:23941647..23941672,-!p2@ZNF681!0.54!4.55!ZNF681;;chr3:170075357..170075368,+!p3@SKIL!0.54!4.27!SKIL;;chr17:42295777..42295816,-!p7@UBTF!0.54!3.13!UBTF;;chr3:75834687..75834720,-!p1@ZNF717!0.53!15.08!ZNF717;;chr6:126102292..126102329,+!p3@NCOA7!0.53!9.68!NCOA7;;chr17:38465413..38465438,+!p5@RARA!0.53!4.27!RARA;;chr20:52185447..52185462,-!p2@ZNF217!0.53!4.27!ZNF217;;chr19:53496806..53496848,-!p2@ZNF702P!0.53!3.98!ZNF702P;;chr19:52552009..52552023,-!p2@ZNF432!0.53!3.42!ZNF432;;chr2:10091815..10091864,+!p1@GRHL1!0.53!3.42!GRHL1;;chr19:58331088..58331106,+!p1@ZNF587!0.52!42.41!ZNF587;;chr19:52873166..52873208,+!p1@ZNF880!0.52!41.27!ZNF880;;chr19:58609577..58609628,-!p1@ZSCAN18!0.52!37.57!ZSCAN18;;chr19:45504688..45504782,+!p1@RELB!0.52!17.65!RELB;;chr19:52800410..52800454,+!p1@ZNF480!0.52!12.81!ZNF480;;chr6:20402102..20402152,+!p1@E2F3!0.52!11.95!E2F3;;chr8:86089417..86089440,+!p2@E2F5!0.52!5.41!E2F5;;chr14:23755247..23755278,-!p2@HOMEZ!0.52!5.41!HOMEZ;;chr17:41623075..41623101,-!p9@ETV4!0.52!2.85!ETV4;;chr6:1612248..1612281,+!p2@FOXC1!0.52!2.56!FOXC1;;chr7:156803329..156803362,-!p1@MNX1!0.52!2.28!MNX1;;chr7:27170274..27170308,-!p3@HOXA4!0.52!2.28!HOXA4;;chr7:97840743..97840786,+!p1@BHLHA15!0.52!2.28!BHLHA15;;chr8:102504979..102505010,+!p2@GRHL2!0.52!2.28!GRHL2;;chr19:47523058..47523114,+!p1@NPAS1!0.52!2.28!NPAS1;;chr22:24093154..24093183,-!p2@ZNF70!0.52!2.28!ZNF70;;chr3:111314186..111314204,-!p1@ZBED2!0.52!2.28!ZBED2;;chr3:128207349..128207386,-!p3@GATA2!0.52!2.28!GATA2;;chr3:69811882..69811898,+!p6@MITF!0.52!2.28!MITF;;chr3:69812701..69812729,+!p9@MITF!0.52!2.28!MITF;;chr12:54410664..54410684,+!p1@HOXC4,p1@HOXC5,p1@HOXC6!0.52!2.28!HOXC5;;chr12:54447686..54447704,+!p5@HOXC4!0.52!2.28!HOXC4;;chr12:66218923..66218934,+!p14@HMGA2!0.52!2.28!HMGA2;;chrX:2418598..2418621,-!p2@ZBED1!0.52!2.28!ZBED1;;chr16:31724552..31724617,+!p1@ZNF720!0.51!40.70!ZNF720;;chr12:133707204..133707236,+!p1@ZNF10,p2@ZNF268!0.51!16.22!ZNF10;;chr1:247242048..247242098,-!p1@ZNF670,p1@ZNF695!0.51!10.25!ZNF670;;chr19:36391434..36391450,-!p1@NFKBID!0.51!5.12!NFKBID;;chr10:43134047..43134079,-!p3@ZNF33B!0.51!3.42!ZNF33B;;chr12:124457746..124457828,+!p1@ZNF664!0.50!108.15!ZNF664;;chr12:95467267..95467350,-!p1@NR2C1!0.50!33.58!NR2C1;;chr1:61548069..61548102,+!p3@NFIA!0.50!6.26!NFIA;;chr7:64254834..64254854,+!p2@ZNF138!0.50!4.55!ZNF138;;chr16:29818199..29818216,+!p11@MAZ!0.50!3.98!MAZ;;chr19:37019569..37019593,-!p2@ZNF260!0.50!3.98!ZNF260;;chr19:39390652..39390663,+!p3@NFKBIB!0.50!3.13!NFKBIB;;chr5:124082580..124082603,-!p4@ZNF608!0.50!2.56!ZNF608;;chr12:133758072..133758114,+!p1@ZNF268!0.49!24.76!ZNF268;;chr14:35872962..35873025,-!p3@NFKBIA!0.49!6.55!NFKBIA;;chr8:28347737..28347785,-!p1@FBXO16,p2@ZNF395!0.49!5.41!ZNF395;;chr19:58400344..58400364,-!p2@ZNF814!0.49!3.42!ZNF814;;chr17:79881332..79881348,-!p3@MAFG!0.49!3.42!MAFG;;chr7:27779729..27779819,+!p1@TAX1BP1!0.48!173.61!TAX1BP1;;chr12:50479109..50479146,+!p2@SMARCD1!0.48!46.68!SMARCD1;;chr19:53193731..53193767,-!p1@ZNF83!0.48!24.48!ZNF83;;chr14:74226961..74227020,-!p1@C14orf43!0.48!17.65!C14orf43;;chr19:56146352..56146420,+!p2@ZNF580,p2@ZNF581!0.48!17.36!ZNF580;;chr15:71184724..71184778,-!p1@THAP10!0.48!9.68!THAP10;;chr7:74072135..74072171,+!p2@GTF2I!0.48!7.97!GTF2I;;chr7:99070527..99070542,+!p2@ZNF789!0.48!5.41!ZNF789;;chr3:24536253..24536328,-!p1@THRB!0.48!4.55!THRB;;chr19:58373157..58373159,+!p4@ZNF587!0.48!4.27!ZNF587;;chr1:43148625..43148710,+!p3@YBX1!0.48!4.27!YBX1;;chr9:14314106..14314119,-!p5@NFIB!0.48!4.27!NFIB;;chr14:33408072..33408114,+!p2@NPAS3!0.48!2.56!NPAS3;;chr10:28032421..28032494,-!p2@MKX!0.48!1.99!MKX;;chr12:85673977..85674015,+!p1@ALX1!0.48!1.99!ALX1;;chr2:180427304..180427323,-!p7@ZNF385B!0.48!1.99!ZNF385B;;chr2:73520667..73520683,-!p1@EGR4!0.48!1.99!EGR4;;chr3:185784049..185784050,-!p7@ETV5!0.48!1.99!ETV5;;chr3:69812798..69812824,+!p8@MITF!0.48!1.99!MITF;;chr19:52408192..52408200,-!p4@ZNF649!0.48!1.99!ZNF649;;chr1:24646002..24646013,+!p3@GRHL3!0.48!1.99!GRHL3;;chr1:40367668..40367684,-!p2@MYCL1!0.48!1.99!MYCL1;;chr6:10413188..10413249,-!p7@TFAP2A!0.48!1.99!TFAP2A;;chr7:27153443..27153450,-!p8@HOXA3!0.48!1.99!HOXA3;;chr15:80696666..80696700,+!p4@ARNT2!0.48!1.99!ARNT2;;chr17:36105074..36105086,-!p2@HNF1B!0.48!1.99!HNF1B;;chr17:46655672..46655697,-!p3@HOXB4!0.48!1.99!HOXB4;;chr19:22235310..22235319,+!p2@ZNF257!0.48!1.99!ZNF257;;chr3:129158715..129158766,-!p2@MBD4!0.47!25.33!MBD4;;chr19:52598958..52599026,-!p1@ZNF841!0.47!25.05!ZNF841;;chr19:40562072..40562143,-!p1@ZNF780B!0.47!23.91!ZNF780B;;chr19:37019136..37019178,-!p1@ZNF260!0.47!21.63!ZNF260;;chr7:64023441..64023462,-!p1@ZNF680!0.47!20.78!ZNF680;;chr19:56879653..56879743,+!p1@ZNF542!0.47!19.35!ZNF542;;chr19:21264991..21265026,+!p1@ZNF714!0.47!17.08!ZNF714;;chr3:185826764..185826803,-!p2@ETV5!0.47!9.39!ETV5;;chr19:44331493..44331552,+!p1@ZNF283!0.47!9.11!ZNF283;;chr6:126102254..126102289,+!p5@NCOA7!0.47!6.83!NCOA7;;chr19:44905759..44905797,-!p2@ZFP112,p2@ZNF285!0.47!5.41!ZNF285;;chr1:935398..935465,-!p2@HES4!0.47!4.84!HES4;;chr9:14082760..14082775,-!p6@NFIB!0.47!3.70!NFIB;;chr11:130184644..130184662,-!p5@ZBTB44!0.47!3.70!ZBTB44;;chr3:32023232..32023273,+!p1@ZNF860!0.47!3.13!ZNF860;;chr9:127533519..127533573,-!p2@NR6A1!0.47!2.56!NR6A1;;chr7:1577111..1577132,+!p4@MAFK!0.47!2.28!MAFK;;chr10:38146482..38146507,-!p4@ZNF248!0.47!2.28!ZNF248;;chr18:3447617..3447633,+!p20@TGIF1!0.47!2.28!TGIF1;;chr20:30795511..30795562,-!p1@PLAGL2!0.46!47.25!PLAGL2;;chr19:37808778..37808827,+!p1@HKR1!0.46!28.46!HKR1;;chr1:246729544..246729572,-!p1@TFB2M!0.46!25.05!TFB2M;;chr17:47439437..47439533,-!p1@ZNF652!0.46!20.78!ZNF652;;chr19:58459047..58459083,-!p1@ZNF256!0.46!12.24!ZNF256;;chr1:117602932..117602973,+!p1@TTF2!0.46!9.11!TTF2;;chr8:128749984..128750033,+!p4@MYC!0.46!8.82!MYC;;chr7:99102592..99102620,+!p3@ZKSCAN5!0.46!5.12!ZKSCAN5;;chr17:15689487..15689505,+!p@chr17:15689487..15689505,+!0.46!3.70!MEIS3P1;;chr2:166326200..166326216,+!p1@CSRNP3!0.46!3.13!CSRNP3;;chr18:3450161..3450183,+!p1@TGIF1!0.45!88.23!TGIF1;;chr19:58011258..58011317,+!p1@ZNF773!0.45!19.07!ZNF773;;chr2:46524474..46524491,+!p4@EPAS1!0.45!5.41!EPAS1;;chr6:27356745..27356777,+!p1@ZNF391!0.45!3.42!ZNF391;;chr12:125003087..125003141,-!p4@NCOR2!0.45!2.56!NCOR2;;chr17:41623259..41623278,-!p7@ETV4!0.45!2.28!ETV4;;chr14:75745523..75745537,+!p1@FOS!0.44!301.40!FOS;;chr8:128748308..128748324,+!p2@MYC!0.44!70.01!MYC;;chr16:69599899..69599919,+!p2@NFAT5!0.44!27.89!NFAT5;;chr19:53141584..53141625,-!p2@ZNF83!0.44!19.35!ZNF83;;chr15:67357924..67357952,+!p2@SMAD3!0.44!15.94!SMAD3;;chr20:42295713..42295738,+!p2@MYBL2!0.44!14.23!MYBL2;;chr10:51572408..51572454,+!p3@NCOA4!0.44!14.23!NCOA4;;chr19:57988878..57988941,-!p1@ZNF772!0.44!13.38!ZNF772;;chr12:80084333..80084380,-!p4@PAWR!0.44!11.67!PAWR;;chr21:27107465..27107557,+!p3@GABPA!0.44!8.54!GABPA;;chr16:30538079..30538124,-!p3@ZNF768!0.44!6.55!ZNF768;;chr8:145669791..145669834,-!p1@TONSL!0.44!6.55!TONSL;;chr22:22863052..22863133,-!p1@ZNF280B!0.44!5.98!ZNF280B;;chr1:33721900..33721921,+!p2@ZNF362!0.44!5.41!ZNF362;;chr12:80084279..80084293,-!p8@PAWR!0.44!3.42!PAWR;;chr10:114711019..114711041,+!p7@TCF7L2!0.44!3.13!TCF7L2;;chr20:35202909..35202963,+!p2@TGIF2,p3@C20orf24!0.44!2.85!TGIF2;;chr16:3333375..3333388,+!p3@ZNF263!0.44!2.85!ZNF263;;chr20:48809000..48809053,+!p12@CEBPB!0.44!2.56!CEBPB;;chr12:27485889..27485900,+!p4@ARNTL2!0.44!2.28!ARNTL2;;chr19:39390697..39390713,+!p4@NFKBIB!0.44!1.99!NFKBIB;;chr6:168227552..168227609,+!p1@MLLT4!0.43!19.35!MLLT4;;chr19:40596828..40596855,-!p1@ZNF780A!0.43!9.68!ZNF780A;;chr8:123794102..123794160,+!p3@ZHX2!0.43!5.98!ZHX2;;chr19:53970970..53971021,+!p1@ZNF813!0.43!5.12!ZNF813;;chr5:76383070..76383117,-!p3@ZBED3!0.43!4.27!ZBED3;;chr20:50808667..50808729,-!p3@ZFP64!0.43!3.98!ZFP64;;chr19:42788636..42788660,+!p1@CIC!0.43!3.42!CIC;;chr14:105886300..105886316,+!p2@MTA1!0.43!3.13!MTA1;;chr19:58978463..58978476,+!p2@ZNF324!0.43!2.85!ZNF324;;chr19:38183166..38183184,-!p3@ZNF781!0.43!1.71!ZNF781;;chr1:24645832..24645853,+!p1@GRHL3!0.43!1.71!GRHL3;;chr20:30433396..30433414,-!p1@FOXS1!0.43!1.71!FOXS1;;chr6:152011654..152011682,+!p1@ESR1!0.43!1.71!ESR1;;chr7:27153590..27153608,-!p7@HOXA3!0.43!1.71!HOXA3;;chr7:27213696..27213713,-!p10@HOXA10!0.43!1.71!HOXA10;;chr7:27219754..27219759,-!p16@HOXA10!0.43!1.71!HOXA10;;chr7:99680193..99680204,-!p2@ZNF3!0.43!1.71!ZNF3;;chr8:11561684..11561751,+!p1@GATA4!0.43!1.71!GATA4;;chr8:76319850..76319870,+!p4@HNF4G!0.43!1.71!HNF4G;;chr8:77593448..77593471,+!p2@ZFHX4!0.43!1.71!ZFHX4;;chr8:86089472..86089483,+!p9@E2F5!0.43!1.71!E2F5;;chr22:22874610..22874616,-!p1@ZNF280A!0.43!1.71!ZNF280A;;chr2:105470614..105470625,+!p@chr2:105470614..105470625,+!0.43!1.71!POU3F3;;chr2:176994408..176994492,+!p1@HOXD8!0.43!1.71!HOXD8;;chr3:168865144..168865160,-!p6@MECOM!0.43!1.71!MECOM;;chr4:111544254..111544270,-!p3@PITX2!0.43!1.71!PITX2;;chr12:54410639..54410659,+!p2@HOXC4,p2@HOXC5,p2@HOXC6!0.43!1.71!HOXC5;;chr12:54422217..54422239,+!p3@HOXC6!0.43!1.71!HOXC6;;chr13:100623360..100623373,-!p2@ZIC5!0.43!1.71!ZIC5;;chr15:67458836..67458859,+!p22@SMAD3!0.43!1.71!SMAD3;;chr18:55102806..55102847,+!p3@ONECUT2!0.43!1.71!ONECUT2;;chr19:22034784..22034801,-!p4@ZNF43!0.43!1.71!ZNF43;;chr6:44233252..44233296,-!p1@NFKBIE!0.42!23.05!NFKBIE;;chr19:52531600..52531685,-!p1@ZNF614!0.42!21.63!ZNF614;;chr12:19592405..19592492,+!p2@AEBP2!0.42!20.21!AEBP2;;chr1:93544821..93544861,+!p1@MTF2!0.42!18.22!MTF2;;chr19:36909528..36909581,-!p1@ZFP82!0.42!10.25!ZFP82;;chr7:138666053..138666146,-!p1@KIAA1549!0.42!9.39!KIAA1549;;chr19:37958086..37958150,-!p1@ZNF569!0.42!8.54!ZNF569;;chr11:65667884..65667895,-!p2@FOSL1!0.42!8.54!FOSL1;;chr1:249132556..249132573,+!p3@ZNF672!0.42!6.26!ZNF672;;chr19:37096139..37096170,-!p2@ZNF529!0.42!5.98!ZNF529;;chr1:91487774..91487802,-!p2@ZNF644!0.42!5.69!ZNF644;;chr19:53662295..53662319,-!p1@ZNF347!0.42!5.41!ZNF347;;chr1:226595726..226595737,-!p2@PARP1!0.42!5.12!PARP1;;chr19:37406934..37406949,-!p1@ZNF829!0.42!3.42!ZNF829;;chr12:50479101..50479108,+!p3@SMARCD1!0.42!3.13!SMARCD1;;chr9:4299979..4299996,-!p3@GLIS3!0.42!3.13!GLIS3;;chr19:58666399..58666438,-!p3@ZNF329!0.42!2.85!ZNF329;;chr9:4300004..4300015,-!p6@GLIS3!0.42!1.99!GLIS3;;chr19:56632592..56632670,-!p1@ZNF787!0.41!52.08!ZNF787;;chr1:61548225..61548299,+!p1@NFIA!0.41!29.88!NFIA;;chr20:32274179..32274213,-!p1@E2F1!0.41!15.08!E2F1;;chr12:2986206..2986258,-!p2@FOXM1!0.41!13.66!FOXM1;;chr12:53774567..53774658,+!p2@SP1!0.41!10.82!SP1;;chr19:58662139..58662182,-!p1@ZNF329!0.41!10.53!ZNF329;;chr19:53466095..53466149,-!p1@ZNF321P,p1@ZNF816-ZNF321P,p1@ZNF816!0.41!9.11!ZNF816;;chr19:53868940..53868990,+!p1@ZNF525,p2@ZNF765!0.41!5.98!ZNF525;;chr19:58920102..58920149,+!p2@ZNF584!0.41!5.12!ZNF584;;chr3:107241882..107241904,+!p2@BBX!0.41!5.12!BBX;;chr19:20011775..20011800,+!p2@ZNF93!0.41!3.42!ZNF93;;chr16:30569604..30569629,-!p3@ZNF764!0.41!2.85!ZNF764;;chr19:53324884..53324886,-!p1@ZNF28!0.41!2.56!ZNF28;;chr14:24025106..24025172,-!p2@ZFHX2!0.41!2.28!ZFHX2;;chr22:42666624..42666673,-!p@chr22:42666624..42666673,-!0.40!24.76!TCF20;;chr4:331578..331615,+!p1@ZNF141!0.40!24.48!ZNF141;;chr4:53206..53260,+!p1@ZNF595,p1@ZNF718!0.40!21.35!ZNF595;;chr19:57999101..57999158,+!p1@ZNF419!0.40!15.08!ZNF419;;chr1:227751231..227751273,+!p1@ZNF678!0.40!13.95!ZNF678;;chr3:44596679..44596726,+!p1@ZNF167!0.40!9.39!ZNF167;;chr10:35415882..35415941,+!p4@CREM!0.40!9.39!CREM;;chr6:28411241..28411284,-!p1@ZSCAN23!0.40!6.55!ZSCAN23;;chr12:96588368..96588394,+!p3@ELK3!0.40!5.41!ELK3;;chr19:21203481..21203504,+!p2@ZNF430!0.40!4.55!ZNF430;;chr6:26659967..26659982,-!p1@ZNF322P1,p1@ZNF322!0.40!3.98!ZNF322;;chr3:44626446..44626477,+!p1@ZNF660!0.40!3.42!ZNF660;;chr17:47492203..47492214,-!p3@PHB!0.40!2.85!PHB;;chr20:42143136..42143161,+!p3@L3MBTL1!0.40!2.85!L3MBTL;;chr9:4299959..4299974,-!p4@GLIS3!0.40!2.85!GLIS3;;chr14:105886349..105886360,+!p3@MTA1!0.40!2.56!MTA1;;chr14:105886290..105886299,+!p5@MTA1!0.40!2.28!MTA1;;chr14:75988771..75988826,+!p1@BATF!0.40!2.28!BATF;;chr7:150065733..150065752,+!p4@REPIN1,p4@ZNF775!0.40!1.99!ZNF775;;chr19:50432453..50432468,+!p1@ATF5!0.39!124.66!ATF5;;chr14:100705140..100705188,+!p2@YY1!0.39!31.59!YY1;;chr11:130184753..130184824,-!p1@ZBTB44!0.39!29.88!ZBTB44;;chr9:14314566..14314618,-!p1@NFIB!0.39!26.47!NFIB;;chr17:70117153..70117174,+!p1@SOX9!0.39!22.48!SOX9;;chr6:43139153..43139232,+!p1@SRF!0.39!20.78!SRF;;chr14:55493763..55493824,-!p1@WDHD1!0.39!16.22!WDHD1;;chr19:58361185..58361235,+!p2@ZNF587!0.39!11.38!ZNF587;;chr12:11802753..11802834,+!p2@ETV6!0.39!10.25!ETV6;;chr19:53758094..53758147,-!p1@ZNF677!0.39!7.68!ZNF677;;chr19:53445819..53445860,-!p2@ZNF321P,p2@ZNF816-ZNF321P,p2@ZNF816!0.39!5.98!ZNF321P;;chr12:133656995..133657049,+!p2@ZNF140!0.39!4.84!ZNF140;;chr12:133613937..133613994,+!p2@ZNF84!0.39!4.55!ZNF84;;chr1:158979851..158979865,+!p5@IFI16!0.39!4.27!IFI16;;chr4:87928307..87928321,+!p8@AFF1!0.39!4.27!AFF1;;chr12:80084862..80084884,-!p7@PAWR!0.39!3.98!PAWR;;chr19:21950332..21950356,-!p2@ZNF100!0.39!3.98!ZNF100;;chr6:28973366..28973394,-!p2@ZNF311!0.39!1.99!ZNF311;;chr2:187350973..187351072,+!p1@ZC3H15!0.38!190.69!ZC3H15;;chr17:47439568..47439641,-!p2@ZNF652!0.38!11.67!ZNF652;;chr17:4981745..4981810,+!p1@ZFP3!0.38!9.96!ZFP3;;chr19:21106081..21106115,+!p2@ZNF85!0.38!5.69!ZNF85;;chr19:20150301..20150321,-!p1@ZNF682!0.38!4.84!ZNF682;;chr1:164528616..164528660,+!p5@PBX1!0.38!3.70!PBX1;;chr4:206390..206444,+!p1@ZNF876P!0.38!3.13!ZNF876P;;chr19:17356189..17356221,-!p2@NR2F6!0.38!2.85!NR2F6;;chr4:87857491..87857519,+!p10@AFF1!0.38!2.28!AFF1;;chr1:247095286..247095297,-!p4@AHCTF1!0.38!2.28!AHCTF1;;chr1:91487013..91487070,-!p6@ZNF644!0.38!2.28!ZNF644;;chr19:35417939..35417963,+!p3@ZNF30!0.38!1.99!ZNF30;;chr3:129158696..129158703,-!p4@MBD4!0.38!1.99!MBD4;;chr5:124080203..124080258,-!p5@ZNF608!0.38!1.71!ZNF608;;chr17:53342311..53342400,+!p1@HLF!0.38!1.71!HLF;;chr17:40719286..40719299,+!p6@MLX!0.38!1.42!MLX;;chr17:41277334..41277348,-!p6@BRCA1!0.38!1.42!BRCA1;;chr17:46675608..46675618,-!p10@HOXB6!0.38!1.42!HOXB6;;chr17:7197911..7197964,-!p1@YBX2!0.38!1.42!YBX2;;chr17:79881433..79881452,-!p6@MAFG!0.38!1.42!MAFG;;chr19:22605097..22605121,-!p2@ZNF98!0.38!1.42!ZNF98;;chr22:24093130..24093141,-!p4@ZNF70!0.38!1.42!ZNF70;;chr2:177001336..177001357,+!p2@HOXD3!0.38!1.42!HOXD3;;chr2:180427245..180427256,-!p12@ZNF385B!0.38!1.42!ZNF385B;;chr2:200322229..200322251,-!p3@SATB2!0.38!1.42!SATB2;;chr2:63277948..63277974,+!p1@OTX1!0.38!1.42!OTX1;;chr3:12329339..12329356,+!p5@PPARG!0.38!1.42!PPARG;;chr3:141868189..141868200,-!p9@TFDP2!0.38!1.42!TFDP2;;chr3:168865323..168865337,-!p15@MECOM!0.38!1.42!MECOM;;chr3:181429704..181429722,+!p1@SOX2!0.38!1.42!SOX2;;chr3:24536231..24536249,-!p4@THRB!0.38!1.42!THRB;;chr3:69811858..69811881,+!p5@MITF!0.38!1.42!MITF;;chr4:149366111..149366128,-!p7@NR3C2!0.38!1.42!NR3C2;;chr19:38210552..38210570,-!p2@ZNF607!0.38!1.42!ZNF607;;chr19:54024313..54024361,+!p7@ZNF331!0.38!1.42!ZNF331;;chr1:197886461..197886558,+!p1@LHX9!0.38!1.42!LHX9;;chr1:40367692..40367703,-!p3@MYCL1!0.38!1.42!MYCL1;;chr5:124082428..124082439,-!p16@ZNF608!0.38!1.42!ZNF608;;chr6:126240490..126240501,+!p11@NCOA7!0.38!1.42!NCOA7;;chr6:1612300..1612324,+!p3@FOXC1!0.38!1.42!FOXC1;;chr7:27213808..27213816,-!p11@HOXA10!0.38!1.42!HOXA10;;chr7:73038867..73038878,-!p2@MLXIPL!0.38!1.42!MLXIPL;;chr7:96654026..96654061,-!p2@DLX5!0.38!1.42!DLX5;;chr8:77596014..77596033,+!p6@ZFHX4!0.38!1.42!ZFHX4;;chr8:86089498..86089519,+!p6@E2F5!0.38!1.42!E2F5;;chr9:100615546..100615558,+!p4@FOXE1!0.38!1.42!FOXE1;;chr9:124976185..124976212,-!p4@LHX6!0.38!1.42!LHX6;;chr10:64576035..64576046,-!p2@EGR2!0.38!1.42!EGR2;;chr12:106994905..106994954,+!p6@RFX4!0.38!1.42!RFX4;;chr12:125003168..125003180,-!p15@NCOR2!0.38!1.42!NCOR2;;chr12:54378864..54378884,+!p6@HOXC10!0.38!1.42!HOXC10;;chr12:54779511..54779577,-!p5@ZNF385A!0.38!1.42!ZNF385A;;chr12:66357586..66357600,+!p20@HMGA2!0.38!1.42!HMGA2;;chr1:226595741..226595818,-!p1@PARP1!0.37!110.14!PARP1;;chr11:118307179..118307223,+!p1@MLL!0.37!64.61!MLL;;chr1:235491462..235491510,-!p1@ARID4B!0.37!38.42!ARID4B;;chr19:23578226..23578285,-!p1@ZNF91!0.37!35.58!ZNF91;;chr16:4322832..4322907,-!p1@TFAP4!0.37!15.65!TFAP4;;chr12:133562959..133563013,+!p1@ZNF26!0.37!13.66!ZNF26;;chr12:7079780..7079791,-!p2@PHB2!0.37!10.53!PHB2;;chr3:150126759..150126784,+!p2@TSC22D2!0.37!9.11!TSC22D2;;chr6:20403916..20403965,+!p3@E2F3!0.37!8.82!E2F3;;chr19:44576296..44576343,+!p2@ZNF284!0.37!7.68!ZNF284;;chr19:20011744..20011770,+!p1@ZNF93!0.37!7.68!ZNF93;;chr19:22034809..22034878,-!p2@ZNF43!0.37!6.83!ZNF43;;chr7:19157248..19157268,-!p1@TWIST1!0.37!5.12!TWIST1;;chr5:124084493..124084524,-!p2@ZNF608!0.37!3.98!ZNF608;;chr20:48807171..48807234,+!p4@CEBPB!0.37!3.98!CEBPB;;chr12:133706820..133706881,-!p1@ZNF891!0.37!3.70!ZNF891;;chr12:48298765..48298783,-!p2@VDR!0.37!3.70!VDR;;chr17:79885633..79885645,-!p4@MAFG!0.37!2.85!MAFG;;chr6:1610293..1610310,+!p1@FOXC1!0.37!2.85!FOXC1;;chr1:93544791..93544807,+!p2@MTF2!0.37!2.56!MTF2;;chr1:164528297..164528309,+!p9@PBX1!0.37!1.99!PBX1;;chr12:12764917..12764931,+!p4@CREBL2!0.37!1.99!CREBL2;;chr16:4366005..4366016,+!p@chr16:4366005..4366016,+!0.37!1.99!GLIS2;;chr19:37407411..37407451,+!p3@ZNF568!0.37!1.99!ZNF568;;chr3:168865194..168865245,-!p3@MECOM!0.37!1.99!MECOM;;chr1:78444738..78444773,-!p1@FUBP1!0.36!221.43!FUBP1;;chr7:111846741..111846776,+!p1@ZNF277!0.36!42.69!ZNF277;;chr19:9695169..9695188,-!p1@ZNF121!0.36!36.15!ZNF121;;chr19:56092195..56092248,-!p1@ZNF579!0.36!21.91!ZNF579;;chr3:179040767..179040866,+!p1@ZNF639!0.36!20.78!ZNF639;;chr1:8877692..8877732,-!p1@RERE!0.36!16.22!RERE;;chr19:57901208..57901280,+!p1@ZNF548!0.36!15.94!ZNF548;;chr12:54772960..54773015,-!p3@ZNF385A!0.36!9.39!ZNF385A;;chr19:19496624..19496660,+!p3@GATAD2A!0.36!8.82!GATAD2A;;chr19:20959098..20959117,+!p1@ZNF66P!0.36!7.97!ZNF66P;;chr5:178157651..178157689,-!p1@ZNF354A!0.36!7.97!ZNF354A;;chr10:94449703..94449718,+!p1@HHEX!0.36!7.40!HHEX;;chr4:87928328..87928351,+!p6@AFF1!0.36!4.84!AFF1;;chr19:46271505..46271575,-!p2@SIX5!0.36!4.55!SIX5;;chr20:49547731..49547753,-!p4@ADNP!0.36!4.55!ADNP;;chr7:64126535..64126559,+!p2@ZNF107!0.36!3.70!ZNF107;;chr19:20150268..20150298,-!p2@ZNF682!0.36!3.13!ZNF682;;chrX:56258811..56258838,+!p2@KLF8!0.36!1.99!KLF8;;chr17:41623667..41623682,-!p8@ETV4!0.36!1.42!ETV4;;chr3:12329320..12329338,+!p4@PPARG!0.36!1.42!PPARG;;chr6:21593973..21593988,+!p1@SOX4!0.35!73.43!SOX4;;chr4:467892..467963,-!p1@ABCA11P,p1@ZNF721!0.35!50.66!ZNF721;;chr7:6746529..6746591,-!p1@ZNF12!0.35!27.61!ZNF12;;chr3:40566428..40566480,+!p1@ZNF621!0.35!15.65!ZNF621;;chr8:146228270..146228295,-!p1@ZNF252!0.35!10.82!ZNF252P;;chr19:44439387..44439419,-!p2@ZNF45!0.35!6.83!ZNF45;;chrX:101186981..101187030,-!p1@ZMAT1!0.35!5.98!ZMAT1;;chr9:14083467..14083483,-!p4@NFIB!0.35!4.27!NFIB;;chr6:56954830..56954845,+!p3@ZNF451!0.35!3.70!ZNF451;;chr6:151712732..151712763,-!p3@ZBTB2!0.35!3.42!ZBTB2;;chr17:79885537..79885554,-!p2@MAFG!0.35!3.13!MAFG;;chr19:24097706..24097731,+!p2@ZNF726!0.35!3.13!ZNF726;;chr19:36980756..36980795,-!p3@ZNF566!0.35!2.56!ZNF566;;chr19:47922750..47922795,-!p1@MEIS3!0.35!2.56!MEIS3;;chr19:57019215..57019250,+!p1@ZNF471!0.35!2.28!ZNF471;;chr12:54694758..54694805,-!p1@NFE2!0.35!1.71!NFE2;;chr6:126240356..126240379,+!p7@NCOA7!0.35!1.71!NCOA7;;chr19:58125580..58125639,+!p1@ZNF134!0.34!31.31!ZNF134;;chr1:247495140..247495177,-!p1@ZNF496!0.34!21.06!ZNF496;;chr1:247095236..247095283,-!p2@AHCTF1!0.34!20.49!AHCTF1;;chr6:41514078..41514158,+!p1@FOXP4!0.34!17.36!FOXP4;;chr1:167190091..167190156,+!p1@POU2F1!0.34!15.08!POU2F1;;chr2:10183651..10183713,+!p1@KLF11!0.34!13.95!KLF11;;chr19:52643169..52643199,-!p1@ZNF616!0.34!11.10!ZNF616;;chr7:64363638..64363667,+!p1@ZNF273!0.34!9.39!ZNF273;;chr19:58193338..58193386,+!p1@ZNF551,p2@ZNF776!0.34!9.11!ZNF551;;chr10:96122645..96122675,-!p2@NOC3L!0.34!8.82!NOC3L;;chrX:83757450..83757485,-!p1@HDX!0.34!7.97!HDX;;chr17:5095126..5095169,-!p1@ZNF594!0.34!7.68!ZNF594;;chr16:1429627..1429662,-!p2@UNKL!0.34!5.12!UNKL;;chr19:35168633..35168652,+!p2@ZNF302!0.34!3.98!ZNF302;;chr2:187350951..187350962,+!p2@ZC3H15!0.34!3.98!ZC3H15;;chr12:56401268..56401305,+!p1@IKZF4!0.34!3.42!IKZF4;;chr5:172484377..172484418,+!p2@C5orf41!0.34!2.56!CREBRF;;chr11:64764435..64764449,-!p1@BATF2!0.34!1.99!BATF2;;chr3:44754176..44754196,+!p2@ZNF502!0.34!1.99!ZNF502;;chr19:50435736..50435781,+!p3@ATF5!0.34!1.99!ATF5;;chr19:57078830..57078848,+!p4@ZNF470!0.34!1.71!ZNF470;;chr1:43148716..43148756,+!p6@YBX1!0.34!1.71!YBX1;;chr6:43140095..43140145,+!p5@SRF!0.34!1.71!SRF;;chr7:14028743..14028799,-!p3@ETV1!0.34!1.71!ETV1;;chr16:30798476..30798483,-!p2@ZNF629!0.34!1.71!ZNF629;;chr17:61919812..61919833,-!p6@SMARCD2!0.34!1.71!SMARCD2;;chr11:706938..707008,-!p3@DEAF1!0.34!1.71!DEAF1;;chr15:76629123..76629151,+!p1@ISL2!0.34!1.42!ISL2;;chr17:7590797..7590815,-!p1@TP53!0.33!83.39!TP53;;chr19:53606636..53606692,-!p1@ZNF160!0.33!34.72!ZNF160;;chr20:42295745..42295765,+!p1@MYBL2!0.33!31.31!MYBL2;;chr17:79885576..79885624,-!p1@MAFG!0.33!21.63!MAFG;;chr20:306489..306564,+!p1@SOX12!0.33!20.49!SOX12;;chr20:49547691..49547724,-!p2@ADNP!0.33!11.38!ADNP;;chr19:44331555..44331581,+!p2@ZNF283!0.33!3.42!ZNF283;;chr1:61548374..61548415,+!p4@NFIA!0.33!2.85!NFIA;;chr19:17356436..17356481,-!p3@NR2F6!0.33!2.56!NR2F6;;chr16:30582888..30582923,-!p3@ZNF688!0.33!2.28!ZNF688;;chr19:57078854..57078889,+!p1@ZNF470!0.33!2.28!ZNF470;;chr3:170076223..170076242,+!p6@SKIL!0.33!1.42!SKIL;;chr21:44441244..44441257,+!p6@PKNOX1!0.33!1.14!PKNOX1;;chr22:22863031..22863050,-!p2@ZNF280B!0.33!1.14!ZNF280B;;chr2:176969228..176969260,+!p1@HOXD11!0.33!1.14!HOXD11;;chr2:177053386..177053402,+!p1@HOXD1!0.33!1.14!HOXD1;;chr2:42721205..42721307,+!p4@MTA3!0.33!1.14!MTA3;;chr2:46612891..46612907,+!p10@EPAS1!0.33!1.14!EPAS1;;chr3:168865364..168865376,-!p11@MECOM!0.33!1.14!MECOM;;chr3:169381183..169381205,-!p4@MECOM!0.33!1.14!MECOM;;chr3:69812745..69812760,+!p10@MITF!0.33!1.14!MITF;;chr4:87857538..87857549,+!p19@AFF1!0.33!1.14!AFF1;;chr15:60296504..60296518,+!p3@FOXB1!0.33!1.14!FOXB1;;chr17:46622143..46622152,-!p14@HOXB2!0.33!1.14!HOXB2;;chr17:46671154..46671167,-!p4@HOXB5!0.33!1.14!HOXB5;;chr17:46671504..46671541,-!p2@HOXB5!0.33!1.14!HOXB5;;chr17:46692287..46692317,-!p7@HOXB8!0.33!1.14!HOXB8;;chr17:48046642..48046667,+!p3@DLX4!0.33!1.14!DLX4;;chr18:3447536..3447542,+!p23@TGIF1!0.33!1.14!TGIF1;;chr9:14314476..14314487,-!p9@NFIB!0.33!1.14!NFIB;;chr9:14083091..14083096,-!p12@NFIB!0.33!1.14!NFIB;;chr9:22446814..22446830,+!p4@DMRTA1!0.33!1.14!DMRTA1;;chr5:124082548..124082571,-!p9@ZNF608!0.33!1.14!ZNF608;;chr5:137800912..137800941,+!p7@EGR1!0.33!1.14!EGR1;;chr7:27224842..27224872,-!p1@HOXA11!0.33!1.14!HOXA11;;chr7:27239740..27239759,-!p2@HOXA13!0.33!1.14!HOXA13;;chr7:27903656..27903678,-!p11@JAZF1!0.33!1.14!JAZF1;;chr7:96635178..96635181,+!p1@DLX6!0.33!1.14!DLX6;;chr8:77595678..77595688,+!p9@ZFHX4!0.33!1.14!ZFHX4;;chr19:38183138..38183157,-!p2@ZNF781!0.33!1.14!ZNF781;;chr19:46367576..46367592,+!p1@FOXA3!0.33!1.14!FOXA3;;chr1:161736032..161736035,+!p6@ATF6!0.33!1.14!ATF6;;chr1:164528866..164528877,+!p12@PBX1!0.33!1.14!PBX1;;chr20:45087928..45087965,-!p1@ENST00000400371,p1@uc002xry.2!0.33!1.14!ZNF663;;chr21:38071462..38071474,+!p3@SIM2!0.33!1.14!SIM2;;chr11:65668011..65668020,-!p3@FOSL1!0.33!1.14!FOSL1;;chr12:54378923..54378966,+!p1@HOXC10!0.33!1.14!HOXC10;;chr12:57917037..57917052,+!p9@MBD6!0.33!1.14!MBD6;;chr13:73636621..73636647,+!p4@KLF5!0.33!1.14!KLF5;;chr13:79177703..79177729,-!p2@POU4F1!0.33!1.14!POU4F1;;chr14:37051600..37051611,-!p2@NKX2-8!0.33!1.14!NKX2-8;;chr1:202777535..202777556,-!p1@KDM5B!0.32!63.18!KDM5B;;chr17:17740287..17740307,-!p1@SREBF1!0.32!48.95!SREBF1;;chr2:113012592..113012671,-!p1@ZC3H8!0.32!31.59!ZC3H8;;chr22:38598086..38598105,+!p1@MAFF!0.32!19.64!MAFF;;chr2:42795745..42795824,+!p1@MTA3!0.32!17.08!MTA3;;chr6:41514305..41514359,+!p2@FOXP4!0.32!15.37!FOXP4;;chr6:21597765..21597779,+!p2@SOX4!0.32!14.80!SOX4;;chr19:58790314..58790358,+!p1@ZNF8!0.32!13.95!ZNF8;;chr19:50529247..50529296,+!p1@ZNF473!0.32!11.67!ZNF473;;chr7:5085480..5085510,+!p1@RBAK!0.32!7.97!RBAK;;chr19:58331073..58331084,+!p3@ZNF587!0.32!6.55!ZNF587;;chr19:44455368..44455396,+!p1@ZNF221!0.32!5.69!ZNF221;;chr7:148581327..148581347,-!p2@EZH2!0.32!5.69!EZH2;;chr1:8763463..8763499,-!p6@RERE!0.32!4.55!RERE;;chr12:122516626..122516645,+!p2@MLXIP!0.32!4.55!MLXIP;;chr5:178450797..178450814,+!p1@ZNF879!0.32!4.27!ZNF879;;chr3:44754126..44754171,+!p1@ZNF502!0.32!3.98!ZNF502;;chr20:48807091..48807123,+!p7@CEBPB!0.32!3.42!CEBPB;;chr3:40547505..40547545,+!p2@ZNF620!0.32!2.28!ZNF620;;chr4:87928085..87928097,+!p17@AFF1!0.32!1.71!AFF1;;chr2:46524865..46524870,+!p9@EPAS1!0.32!1.42!EPAS1;;chr22:29196547..29196563,-!p2@XBP1!0.31!67.45!XBP1;;chr3:193853927..193853944,+!p1@HES1!0.31!60.62!HES1;;chr14:100705458..100705529,+!p1@YY1!0.31!56.35!YY1;;chr19:19516561..19516644,+!p1@GATAD2A!0.31!38.71!GATAD2A;;chr14:45722360..45722415,-!p1@MIS18BP1!0.31!28.18!MIS18BP1;;chr19:36705998..36706021,+!p2@ZNF146!0.31!26.47!ZNF146;;chr19:53935221..53935258,+!p1@ZNF761!0.31!18.22!ZNF761;;chr8:124286495..124286548,-!p1@ZHX1!0.31!17.65!ZHX1;;chr19:12662240..12662310,-!p1@ZNF564,p1@ZNF709!0.31!13.66!ZNF564;;chr20:306177..306211,+!p2@SOX12!0.31!11.95!SOX12;;chr19:56826201..56826247,-!p1@ZSCAN5A!0.31!11.38!ZSCAN5A;;chr9:139294614..139294633,-!p@chr9:139294614..139294633,-!0.31!11.10!SNAPC4;;chr19:21579908..21579949,+!p1@ZNF493!0.31!10.53!ZNF493;;chr7:99070499..99070523,+!p1@ZNF789!0.31!9.11!ZNF789;;chr5:133450365..133450444,+!p1@TCF7!0.31!7.68!TCF7;;chr10:43134001..43134026,-!p1@ZNF33B!0.31!7.68!ZNF33B;;chr19:53030906..53030952,+!p1@ZNF808!0.31!6.26!ZNF808;;chr4:41992565..41992580,+!p2@SLC30A9!0.31!5.98!SLC30A9;;chr19:37569314..37569381,+!p1@ZNF420!0.31!5.98!ZNF420;;chr19:37341752..37341816,+!p1@ZNF345!0.31!4.84!ZNF345;;chr15:66994663..66994680,+!p1@SMAD6!0.31!3.70!SMAD6;;chr12:133758115..133758138,+!p3@ZNF268!0.31!3.70!ZNF268;;chr1:91487836..91487854,-!p3@ZNF644!0.31!3.42!ZNF644;;chr5:150284532..150284549,-!p1@ZNF300!0.31!3.13!ZNF300;;chr1:249132608..249132628,+!p5@ZNF672!0.31!2.56!ZNF672;;chr1:40367530..40367597,-!p1@MYCL1!0.31!2.56!MYCL1;;chrX:101975619..101975641,+!p2@BHLHB9!0.31!2.56!BHLHB9;;chr3:150126101..150126118,+!p6@TSC22D2!0.31!2.28!TSC22D2;;chr3:168864315..168864339,-!p2@MECOM!0.31!2.28!MECOM;;chr6:43139248..43139261,+!p4@SRF!0.31!1.99!SRF;;chr12:51566592..51566617,-!p3@TFCP2!0.31!1.99!TFCP2;;chr3:170075103..170075114,+!p5@SKIL!0.31!1.71!SKIL;;chr11:130184623..130184634,-!p6@ZBTB44!0.31!1.42!ZBTB44;;chr8:28748157..28748175,+!p3@HMBOX1!0.31!1.42!HMBOX1;;chr21:36260980..36261011,-!p1@RUNX1!0.30!52.37!RUNX1;;chr19:50169064..50169121,-!p1@IRF3!0.30!25.33!IRF3;;chr2:148778652..148778672,+!p1@MBD5!0.30!21.63!MBD5;;chr19:49865646..49865718,-!p1@TEAD2!0.30!15.08!TEAD2;;chr12:133657477..133657529,+!p1@ZNF140!0.30!13.38!ZNF140;;chr14:100705200..100705237,+!p3@YY1!0.30!13.38!YY1;;chr14:74318611..74318682,+!p1@PTGR2,p2@ZNF410!0.30!11.67!ZNF410;;chr19:20748574..20748599,-!p1@ZNF737!0.30!10.25!ZNF737;;chr17:56065729..56065781,-!p2@VEZF1!0.30!7.12!VEZF1;;chr1:205601000..205601055,-!p2@ELK4!0.30!6.83!ELK4;;chr19:36870087..36870110,-!p1@ZFP14!0.30!5.98!ZFP14;;chr19:58326267..58326292,-!p1@ZNF552!0.30!5.69!ZNF552;;chr17:41322208..41322250,-!p3@BRCA1!0.30!4.55!BRCA1;;chr19:37862054..37862110,+!p1@ZNF527!0.30!4.27!ZNF527;;chr19:58446721..58446779,-!p1@ZNF418!0.30!4.27!ZNF418;;chr7:104654690..104654704,+!p2@MLL5!0.30!2.85!MLL5;;chr8:116680833..116680881,-!p7@TRPS1!0.30!1.99!TRPS1;;chr4:87928166..87928186,+!p12@AFF1!0.30!1.99!AFF1;;chr19:53466067..53466087,-!p3@ZNF321P,p3@ZNF816-ZNF321P,p3@ZNF816!0.30!1.99!ZNF816;;chr10:111987079..111987115,+!p3@MXI1!0.30!1.71!MXI1;;chr2:192015701..192015743,-!p1@STAT4!0.30!1.71!STAT4;;chr3:14989024..14989041,+!p3@NR2C2!0.30!1.71!NR2C2;;chr4:87967965..87967983,+!p16@AFF1!0.30!1.71!AFF1;;chr19:44764031..44764072,+!p1@ZNF233!0.30!1.42!ZNF233;;chr19:23299814..23299844,+!p1@ZNF730!0.30!1.42!ZNF730;;chr11:85376028..85376035,-!p5@CREBZF!0.30!1.14!CREBZF;;chr7:92076740..92076834,+!p1@GATAD1!0.29!44.11!GATAD1;;chr12:69753448..69753577,+!p1@YEATS4!0.29!34.72!YEATS4;;chr17:73780879..73780963,+!p1@UNK!0.29!29.31!UNK;;chr3:129158768..129158819,-!p1@MBD4!0.29!26.18!MBD4;;chr20:18269151..18269212,+!p1@ZNF133!0.29!14.23!ZNF133;;chr19:58740266..58740297,+!p1@ZNF544!0.29!12.24!ZNF544;;chr14:74226747..74226779,-!p3@C14orf43!0.29!9.11!C14orf43;;chr16:2273645..2273671,+!p2@E4F1!0.29!8.54!E4F1;;chr19:57752022..57752108,+!p1@ZNF805!0.29!7.12!ZNF805;;chr19:23869970..23869991,-!p1@ZNF675!0.29!5.98!ZNF675;;chr3:150126416..150126437,+!p3@TSC22D2!0.29!5.69!TSC22D2;;chr19:58111241..58111292,+!p1@ZNF530!0.29!5.41!ZNF530;;chr19:58326246..58326262,-!p2@ZNF552!0.29!3.42!ZNF552;;chr4:121843844..121843904,-!p1@PRDM5!0.29!3.42!PRDM5;;chr2:71127699..71127744,+!p1@VAX2!0.29!2.85!VAX2;;chr1:26496459..26496470,+!p2@ZNF593!0.29!2.56!ZNF593;;chr1:91487806..91487826,-!p5@ZNF644!0.29!2.28!ZNF644;;chr19:42788611..42788634,+!p2@CIC!0.29!1.99!CIC;;chr7:27788205..27788255,+!p2@TAX1BP1!0.29!1.99!TAX1BP1;;chr19:50431973..50431998,+!p5@ATF5!0.29!1.42!ATF5;;chr12:80083544..80083558,-!p13@PAWR!0.29!1.42!PAWR;;chr19:37960314..37960329,+!p3@ZNF570!0.29!1.42!ZNF570;;chr19:39390667..39390678,+!p7@NFKBIB!0.29!1.14!NFKBIB;;chrX:101187036..101187056,-!p2@ZMAT1!0.29!1.14!ZMAT1;;chr3:47823298..47823423,-!p1@SMARCC1!0.28!58.91!SMARCC1;;chr7:74072021..74072119,+!p1@GTF2I!0.28!44.40!GTF2I;;chr7:99156249..99156311,+!p1@ZNF655!0.28!38.14!ZNF655;;chr1:53018743..53018777,-!p1@ZCCHC11!0.28!29.03!ZCCHC11;;chr14:65569244..65569264,-!p2@MAX!0.28!19.07!MAX;;chr19:52772832..52772861,+!p1@ZNF766!0.28!16.79!ZNF766;;chr4:47916588..47916607,-!p1@NFXL1!0.28!13.66!NFXL1;;chr8:144329092..144329140,+!p1@ZFP41!0.28!11.67!ZFP41;;chr1:155532531..155532605,-!p1@ASH1L!0.28!11.10!ASH1L;;chr3:113415441..113415500,-!p1@KIAA2018!0.28!8.82!KIAA2018;;chr19:37407212..37407280,+!p1@ZNF568!0.28!6.26!ZNF568;;chr1:205600919..205600982,-!p3@ELK4!0.28!5.69!ELK4;;chr19:37096194..37096235,+!p1@ZNF382!0.28!4.84!ZNF382;;chr6:56954867..56954882,+!p2@ZNF451!0.28!4.27!ZNF451;;chr10:38146510..38146576,-!p1@ZNF248!0.28!4.27!ZNF248;;chr11:130184470..130184533,-!p2@ZBTB44!0.28!3.98!ZBTB44;;chr6:20403727..20403769,+!p4@E2F3!0.28!3.42!E2F3;;chr8:116681123..116681143,-!p4@TRPS1!0.28!2.56!TRPS1;;chr8:123793988..123794016,+!p1@ZHX2!0.28!2.28!ZHX2;;chr19:37407172..37407217,-!p2@ZNF829!0.28!2.28!ZNF829;;chrX:129244655..129244697,-!p4@ELF4!0.28!2.28!ELF4;;chr1:27022578..27022589,+!p5@ARID1A!0.28!1.99!ARID1A;;chr19:38183208..38183225,-!p1@ZNF781!0.28!1.42!ZNF781;;chr19:9649253..9649265,-!p3@ZNF426!0.28!1.42!ZNF426;;chr6:21597431..21597447,+!p8@SOX4!0.28!1.42!SOX4;;chr3:44626359..44626387,+!p4@ZNF197!0.28!1.42!ZNF197;;chr11:707063..707088,-!p4@DEAF1!0.28!1.42!DEAF1;;chr14:69262827..69262841,-!p7@ZFP36L1!0.28!1.42!ZFP36L1;;chr14:89029323..89029329,+!p4@ZC3H14!0.28!1.42!ZC3H14;;chr19:20011731..20011743,+!p3@ZNF93!0.28!1.42!ZNF93;;chr19:12551849..12551868,-!p4@ZNF443!0.28!1.14!ZNF443;;chr22:21355896..21355920,-!p4@THAP7!0.28!1.14!THAP7;;chr4:146860163..146860188,-!p5@ZNF827!0.28!1.14!ZNF827;;chr19:47422934..47422958,+!p4@ARHGAP35!0.28!1.14!ARHGAP35;;chr17:46126136..46126152,+!p1@NFE2L1!0.27!87.66!NFE2L1;;chr16:31128978..31129002,+!p1@KAT8!0.27!81.68!KAT8;;chr1:150849047..150849082,-!p1@ARNT!0.27!25.33!ARNT;;chr7:64838754..64838778,+!p1@ZNF92!0.27!15.65!ZNF92;;chr19:21106049..21106072,+!p1@ZNF85!0.27!8.54!ZNF85;;chr7:99102865..99102894,+!p1@ZKSCAN5!0.27!7.68!ZKSCAN5;;chr1:935467..935484,-!p1@HES4!0.27!6.83!HES4;;chr19:38210622..38210681,-!p1@ZNF607!0.27!5.69!ZNF607;;chr19:58920000..58920057,+!p1@ZNF584!0.27!5.69!ZNF584;;chr7:99647389..99647410,+!p1@ZSCAN21!0.27!5.41!ZSCAN21;;chr20:39946361..39946379,-!p2@ZHX3!0.27!4.27!ZHX3;;chr19:37958318..37958365,-!p2@ZNF569!0.27!3.70!ZNF569;;chr17:46655730..46655791,-!p1@HOXB4!0.27!3.42!HOXB4;;chr1:249153232..249153251,-!p2@ZNF692!0.27!3.13!ZNF692;;chr19:56879472..56879529,+!p2@ZNF542!0.27!2.85!ZNF542;;chr16:30621615..30621660,-!p2@ZNF689!0.27!2.28!ZNF689;;chr19:35168547..35168564,+!p3@ZNF302!0.27!1.42!ZNF302;;chr1:27023752..27023799,+!p4@ARID1A!0.27!1.42!ARID1A;;chr20:42136308..42136358,+!p2@L3MBTL1!0.27!1.42!L3MBTL;;chr1:23857325..23857416,-!p2@E2F2!0.27!1.14!E2F2;;chr4:149363544..149363583,-!p3@NR3C2!0.27!1.14!NR3C2;;chr6:20402070..20402082,+!p5@E2F3!0.27!1.14!E2F3;;chr7:106826626..106826630,+!p3@HBP1!0.27!1.14!HBP1;;chr13:73636252..73636307,+!p2@KLF5!0.27!1.14!KLF5;;chr10:104154415..104154434,+!p5@NFKB2!0.27!0.85!NFKB2;;chr10:124768217..124768228,-!p2@IKZF5!0.27!0.85!IKZF5;;chr10:28032548..28032559,-!p7@MKX!0.27!0.85!MKX;;chr11:16419067..16419077,-!p23@SOX6!0.27!0.85!SOX6;;chr11:31832658..31832681,-!p1@PAX6!0.27!0.85!PAX6;;chr11:65480222..65480241,+!p4@KAT5!0.27!0.85!KAT5;;chr12:51157232..51157277,+!p6@ATF1!0.27!0.85!ATF1;;chr12:54379477..54379498,+!p5@HOXC5!0.27!0.85!HOXC5;;chr12:54447219..54447237,+!p6@HOXC4!0.27!0.85!HOXC4;;chr12:80084120..80084136,-!p15@PAWR!0.27!0.85!PAWR;;chr13:100634111..100634118,+!p8@ZIC2!0.27!0.85!ZIC2;;chr14:29234870..29234930,+!p7@FOXG1!0.27!0.85!FOXG1;;chr14:36989427..36989442,-!p1@NKX2-1!0.27!0.85!NKX2-1;;chr14:69260437..69260442,-!p10@ZFP36L1!0.27!0.85!ZFP36L1;;chr14:69263043..69263069,-!p8@ZFP36L1!0.27!0.85!ZFP36L1;;chr2:10091783..10091811,+!p2@GRHL1!0.27!0.85!GRHL1;;chr2:176969179..176969226,+!p2@HOXD11!0.27!0.85!HOXD11;;chr2:176987441..176987454,+!p1@HOXD9!0.27!0.85!HOXD9;;chr2:180427235..180427244,-!p10@ZNF385B!0.27!0.85!ZNF385B;;chr2:191906489..191906517,-!p6@STAT4!0.27!0.85!STAT4;;chr2:237077022..237077038,-!p1@GBX2!0.27!0.85!GBX2;;chr2:60778062..60778075,-!p6@BCL11A!0.27!0.85!BCL11A;;chr3:141868208..141868219,-!p11@TFDP2!0.27!0.85!TFDP2;;chr3:170076246..170076261,+!p8@SKIL!0.27!0.85!SKIL;;chr3:69812731..69812742,+!p19@MITF!0.27!0.85!MITF;;chr3:69812764..69812775,+!p18@MITF!0.27!0.85!MITF;;chr3:69812852..69812864,+!p17@MITF!0.27!0.85!MITF;;chr16:30102849..30102865,-!p2@TBX6!0.27!0.85!TBX6;;chr17:46621146..46621180,-!p10@HOXB2!0.27!0.85!HOXB2;;chr17:46682321..46682362,-!p1@HOXB6!0.27!0.85!HOXB6;;chr17:46691990..46692004,-!p11@HOXB8!0.27!0.85!HOXB8;;chr17:46692624..46692659,-!p3@HOXB8!0.27!0.85!HOXB8;;chr17:46703212..46703238,-!p2@HOXB9!0.27!0.85!HOXB9;;chr17:46703478..46703488,-!p9@HOXB9!0.27!0.85!HOXB9;;chr17:48045917..48045977,+!p1@DLX4!0.27!0.85!DLX4;;chr17:79881409..79881423,-!p8@MAFG!0.27!0.85!MAFG;;chr19:12405588..12405595,-!p4@ZNF44!0.27!0.85!ZNF44;;chr19:12595565..12595576,-!p3@ZNF709!0.27!0.85!ZNF709;;chr19:20188831..20188844,+!p2@ZNF90!0.27!0.85!ZNF90;;chr19:37096126..37096137,-!p4@ZNF529!0.27!0.85!ZNF529;;chr19:37958064..37958076,-!p4@ZNF569!0.27!0.85!ZNF569;;chr19:38183103..38183114,-!p5@ZNF781!0.27!0.85!ZNF781;;chr19:44488402..44488405,+!p3@ZNF155!0.27!0.85!ZNF155;;chr19:44716768..44716775,+!p2@ZNF227!0.27!0.85!ZNF227;;chr19:46806868..46806883,+!p3@HIF3A!0.27!0.85!HIF3A;;chr19:53758167..53758190,-!p3@ZNF677!0.27!0.85!ZNF677;;chr19:57352109..57352153,-!p2@ZIM2!0.27!0.85!ZIM2;;chr1:37945588..37945604,+!p3@ZC3H12A!0.27!0.85!ZC3H12A;;chr1:40105299..40105326,-!p1@HEYL!0.27!0.85!HEYL;;chr20:18038521..18038571,-!p1@OVOL2!0.27!0.85!OVOL2;;chr20:62339469..62339470,+!p10@ZGPAT!0.27!0.85!ZGPAT;;chr5:170736243..170736279,+!p1@TLX3!0.27!0.85!TLX3;;chr5:56248032..56248039,-!p3@MIER3!0.27!0.85!MIER3;;chr6:10412477..10412490,-!p10@TFAP2A!0.27!0.85!TFAP2A;;chr6:10419884..10419898,-!p11@TFAP2A!0.27!0.85!TFAP2A;;chr6:10420285..10420304,-!p18@TFAP2A!0.27!0.85!TFAP2A;;chr6:126102339..126102351,+!p12@NCOA7!0.27!0.85!NCOA7;;chr6:1610178..1610190,+!p5@FOXC1!0.27!0.85!FOXC1;;chr6:1612219..1612239,+!p8@FOXC1!0.27!0.85!FOXC1;;chr6:28322004..28322023,-!p6@ZNF323!0.27!0.85!ZNF323;;chr7:14029004..14029017,-!p8@ETV1!0.27!0.85!ETV1;;chr7:148982396..148982408,+!p4@ZNF783!0.27!0.85!ZNF783;;chr7:150864780..150864785,-!p1@GBX1!0.27!0.85!GBX1;;chr7:27169801..27169844,-!p2@HOXA4!0.27!0.85!HOXA4;; | |||
|ffid_belonging_in_development=CL:0000134,CL:0000223,UBERON:0002532,UBERON:0006603,UBERON:0010316 | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|fonse_cell_line=FF:0101120,FF:0101555 | |fonse_cell_line=FF:0101120,FF:0101555 | ||
|fonse_cell_line_closure=FF:0101120,FF:0101555 | |fonse_cell_line_closure=FF:0101120,FF:0101555 | ||
Line 67: | Line 40: | ||
|fonse_treatment= | |fonse_treatment= | ||
|fonse_treatment_closure= | |fonse_treatment_closure= | ||
|has_quality= | |||
|hg19bam=http://fantom.gsc.riken.jp/5/datafiles/latest/basic/human.cell_line.hCAGE/endometrial%2520carcinoma%2520cell%2520line%253aOMC-2.CNhs11266.10497-107C2.hg19.nobarcode.bam | |||
|hg19ctss=http://fantom.gsc.riken.jp/5/datafiles/latest/basic/human.cell_line.hCAGE/endometrial%2520carcinoma%2520cell%2520line%253aOMC-2.CNhs11266.10497-107C2.hg19.ctss.bed.gz | |||
|hg19fasta=http://fantom.gsc.riken.jp/5/datafiles/latest/basic/human.cell_line.hCAGE/endometrial%2520carcinoma%2520cell%2520line%253aOMC-2.CNhs11266.10497-107C2.hg19.nobarcode.rdna.fa.gz | |||
|hg38bam=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/hg38_v2/basic/human.cell_line.hCAGE/endometrial%2520carcinoma%2520cell%2520line%253aOMC-2.CNhs11266.10497-107C2.hg38.nobarcode.bam | |||
|hg38ctss=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/hg38_v2/basic/human.cell_line.hCAGE/endometrial%2520carcinoma%2520cell%2520line%253aOMC-2.CNhs11266.10497-107C2.hg38.nobarcode.ctss.bed.gz | |||
|id=FF:10497-107C2 | |||
|is_a=EFO:0002091;;FF:0000210;;FF:0100167;;FF:0101555 | |||
|is_obsolete= | |||
|library_id=CNhs11266 | |||
|library_id_phase_based=2:CNhs11266 | |||
|microRNAs= | |||
|microRNAs_nn= | |||
|microRNAs_nonnovel_cage=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2017/vis_viewer/#/human#cage;sample;10497 | |||
|microRNAs_novel_cage=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2017/vis_viewer_novel/#/human#cage;sample;10497 | |||
|name=endometrial carcinoma cell line:OMC-2 | |||
|namespace=FANTOM5 | |||
|part_of= | |||
|profile_cagescan=,,, | |||
|profile_hcage=CNhs11266,LSID758,release008,COMPLETED | |||
|profile_rnaseq= | |||
|profile_srnaseq=,,, | |||
|refex=http://refex.dbcls.jp/genelist.php?lang | |||
|repeat_enrich_byfamily=0,0,0.097841791688246,0,0,0,0,0.169778670527506,0,-0.0215665243725967,-0.282403560576942,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.153323010348428,0,0,0,0,0,-0.0979578962680575,0,0,-0.132956589778862,0,0,0,0,0,0,0,0,0,0,0,0,-0.0412679563442687,0,0,0,0,0,0,0,0,0.0301705513696207,0,0,0,0,0,0,0,0.0117787837223049,0,0,0.170725959676434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0628879301228039,0,0,0.10877114496491,0,0,0,-0.119977956937069,0,0,0,-0.0661980438705507,-0.211197402695869,0.054385572482455,0,0.054385572482455,0,0.0107357937272036,-0.138477200800895,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0.351493109197394,0,0,0,-0.0212163749429062,-0.0584834617220785,0,0,0,0,0,0 | |||
|repeat_enrich_byname=0,0,0,0,0.0107357937272036,0,0,0.195683583376492,0.10877114496491,0,0,0,0.10877114496491,0,0,0,-0.247178875285564,0.0182587066288034,0.450185218750487,0.18658155809042,0,0,-0.104798262569204,0,0,0,0.0079846001480865,0,0,0,0.10877114496491,0,-0.128119866952565,0,-0.0504125515893149,0,0,0,0,0.054385572482455,-0.109788647521915,0,-0.0402232677047442,0.0404268838875418,0,0.0487811961549386,0,0,-0.270240669334324,0,0.0748040995827518,0.0260509766414927,0.254388729113063,-0.628216240879636,0.0903965760059696,0,0,0,-0.583870196815764,-0.140660986869541,0,0,-0.121779851751874,-0.181349618560659,0,0,-0.391044581551635,0,-0.229281239281527,-0.0604397418968705,0,0.0372772831116004,0,0,0,0,0,0,0,0,0,0,0,0.0403483248668096,0.0573733724466302,0,0.10877114496491,0.515460056394663,0,-0.326080952708647,0,0,0.923032997115567,0.0741954176689785,0.00446499789076749,0.339705462080573,0,-0.302389727009913,-0.164056801128682,-0.477044880310587,-0.017052349020345,-0.147401849371139,-0.189981719549847,0,-0.197059427950604,0.166474653130318,0.0445406420097431,0.0425277539826534,-0.0140384063465543,-0.292665801987574,-0.131245387672314,0,0.47600031721587,0,0.214326570467753,0,0.0107301845573853,-0.105752745351175,0.173958125550735,-0.134286681525793,-0.662067061075021,0.0188282010231702,0.329726147481564,0.445158485730544,-0.261752869520102,-0.0680483111078985,-0.367186752421245,0,0,-0.0350172760149896,0.0817912090641023,0.19355825059786,0.0291354755020539,0,-0.21590787492145,0.0404268838875418,0.239287712838294,-0.394462451957321,0.0423314310053096,0.330096700613892,0.173528096674864,-0.194415261745813,0,0,0,0,0,-0.199523688420219,-0.209395442416274,-0.124084416590635,0,0.0733544188105335,0,0.117969492533739,0,0.0653566225666614,-0.104574609327007,0.00135641850508073,-0.0969502212197435,0,-0.241090842509913,0.181056057575233,-0.0562195513740928,-0.422394805391737,0.639177704916966,0.208270772523799,-0.0362898074141256,-0.0661980438705507,0.368717794787873,0.0715504101152016,-0.0881268324752877,0,-0.267520569509014,-0.679498131621524,0,-0.150936211898868,0,0.264365652587236,0,-0.0133892217486935,0,-0.447372438336167,-0.344750168096748,-0.243605791204194,-0.0499539721364302,0,0.160054307072974,-0.788130937773974,0,0,0,0.697624531728791,-0.0415959383697293,-0.0527343178318496,-0.059423063693888,0.175149181174404,0,0.0535761441390659,0,0,0.303969653381154,-0.235476037764389,0.10877114496491,0.170728231057869,0.0628879301228039,0.0678748031409055,-0.00719992847002404,0,0,-0.645700337992725,0,0,-0.275831363204138,0.10877114496491,0.82353126442848,-0.144555196521846,0,-0.108622809454255,0,0,0.0181558174113167,0,-0.39467999825769,0,0,0.153316541748027,-0.116628112990133,0,0,0,0.127215133782602,0,0,0,0,0,0,0,0.225588594539214,0.261190850792919,0,-0.0144678310381854,0,0,0,0.551631231042592,0,0,0,0,0.0248221660229622,-0.0674240369725055,-0.12301741567642,0.152227364170701,0,0,0,0.114373298060418,0.126860138519169,0,0.252499262627967,0.10877114496491,0,0.10877114496491,0,0.18192859710032,0,0,0.292510029624415,0,0.051040687911246,-0.285083633849015,0,0,0,-0.27695440160179,0,0,0,0,-0.081766071927957,0,0,0,0,-0.404645223695685,0.563379769133892,0,0.156974723712325,-0.556781752793047,0.847501987379847,0,0,0.6479541641749,0,0,-0.314204320825507,0,0,-0.0209247759461169,0,0,0,0,0.195683583376492,0,0.646706447316599,0,0,0,0,0.10877114496491,0,0.10877114496491,0,0,0,0,-0.508404248085888,-0.0922240566585104,0,0,0,0,0,0,0,-0.0241060230789031,0.33546705137581,0.000821473642237405,0,0,0,0,0,0,0,0.200664904672958,0.054385572482455,0,0,0,0,0.0117787837223049,0,0,0,0.195683583376492,-0.564807121153884,0,0,-0.0816785488170216,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206777614578445,-0.0215665243725967,0,0,0,0,0,0,0,-0.00676371131655945,0,0,0,0,0.0817992096675152,0,0,0,0.616943616018584,0,0.169778670527506,0,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.307667378368657,0,-0.28720751597291,-0.0568589461625992,0,0,-0.0675800023260955,0,0,0,0,0,0,-0.031340424028527,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.0348580438050884,0,0,0,0,0,0,0,-0.0979578962680575,0,0,-0.0376472373180712,0,0,0,0,0,0,0.088889556166112,-0.283220399823148,-0.0584864311139119,0,0,0,0.165048350306946,0,0,0,0,-0.0667773874189013,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.153323010348428,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10877114496491,0.054385572482455,0,0,0,0,0,0,-0.0340113632754165,0.10877114496491,0,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0.10877114496491,0,0,0,0,0,0,0,0,-0.0800184682686384,0,0,0,0.766384128048139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.909301295964787,0,0,0,0,0,0,0,0,0,0,0,-0.137359280060864,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.0482220752390542,0,0.0243945127348829,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.117910350185009,0,0,0,0,-0.0476371106609188,0,0,0,0,0,0,0,0.008643546657176,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,-0.253610608288505,0,0.10877114496491,0.0392008561467909,0,0,0,0,0,0,0,0,0,0,0,0,-0.0613201791501264,0,0,0,0,0,0,0,0,0,0,0.0603411027392413,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.0302414281958764,-0.0584834617220785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0486229890500127,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.58502005924883,0,0,0,0,0,0,0,0,0,0,0,0,0.0681448693155702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0.0487513457352853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.545774823722273,0,0,0,0,0,0,0,0,0.268069586889531,0,0,0,0,0,0,0,0,0,0.10877114496491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10877114496491,0,0,0,0,0,0,0,0,0,0,0,0,0,0.594215073429878,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.00781193602043905,0,0,0,0,0,0,0,-0.0139248520320909,0,0,0,0.054385572482455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0741020081706845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0226689864340717,0,0,0.10877114496491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.054385572482455,0,0,0,-0.0797419986649781,0,0,0,0,0,0,0,0,0,0,0.53051018823235,0,0,0,0,0,0,0,0.170725959676434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10877114496491,0,0,0,0,0,-0.132956589778862,0,0,0,0,0,0,0,0,0,0,0,0.330096700613892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10877114496491,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.0499379825215864,0,0,0,0,0,0,0,0,0,0,-0.0412500915278073,0.054385572482455,0,0,0,0,0,0,0.054385572482455,0,0,0,0,0,0,0,0,0,0,0.341681787601078,0,0,-0.0422874684771159,0,-0.0237852779987305,-0.0180190342978106,0,0,0,0,0,0.119272993254623,0,0,0,0,0,0,0,0,0,0,0,0.195683583376492,0,0.223531497979976,0,0,0,0,0,0,0.268069586889531,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,-0.0843885119464734,0,-0.0391314215868488,0.118385367872648,0,0,-0.184575240551292,0,0,0,0,0,0.2093690740353,0.094196005094982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.47600031721587,0,-0.0568589461625992,-0.0737920522180767,0,-0.110766667460893,0,0,0.489039857368896,0,0.054385572482455,0,0.336634284957117 | |||
|rna_box=107 | |||
|rna_catalog_number= | |||
|rna_concentration=0.89027 | |||
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0 | |||
|rna_lot_number= | |||
|rna_od260/230=2.12 | |||
|rna_od260/280=2.16 | |||
|rna_position=C2 | |||
|rna_rin= | |||
|rna_sample_type=total RNA | |||
|rna_tube_id=107C2 | |||
|rna_weight_ug=22.25675 | |||
|sample_age=59 | |||
|sample_category=cell lines | |||
|sample_cell_catalog=RCB2830 | |||
|sample_cell_line=OMC-2 | |||
|sample_cell_lot= | |||
|sample_cell_type=unclassifiable | |||
|sample_collaboration=Yukio Nakamura (RIKEN BRC) | |||
|sample_company=RIKEN Bioresource centre | |||
|sample_description= | |||
|sample_dev_stage= | |||
|sample_disease=endometrial carcinoma | |||
|sample_donor(cell lot)= | |||
|sample_ethnicity=J | |||
|sample_experimental_condition= | |||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;1.05686843043264e-265!GO:0043226;organelle;5.28592548926031e-223!GO:0043229;intracellular organelle;1.67990297478565e-222!GO:0043231;intracellular membrane-bound organelle;2.68967280275598e-220!GO:0043227;membrane-bound organelle;2.68967280275598e-220!GO:0005737;cytoplasm;3.09409666449527e-174!GO:0044422;organelle part;1.60002762434976e-139!GO:0044446;intracellular organelle part;6.78811920510862e-138!GO:0044444;cytoplasmic part;4.42662849335575e-121!GO:0005634;nucleus;3.05456243814525e-103!GO:0044237;cellular metabolic process;1.38230450650298e-102!GO:0044238;primary metabolic process;9.95262535331771e-100!GO:0032991;macromolecular complex;6.31282517628699e-94!GO:0043170;macromolecule metabolic process;2.22203962200229e-93!GO:0030529;ribonucleoprotein complex;6.75437694615519e-90!GO:0003723;RNA binding;2.50641082743743e-80!GO:0044428;nuclear part;3.07628062854264e-79!GO:0043233;organelle lumen;4.16419278413432e-79!GO:0031974;membrane-enclosed lumen;4.16419278413432e-79!GO:0005739;mitochondrion;1.34860824710857e-65!GO:0010467;gene expression;2.55352526344872e-61!GO:0005515;protein binding;2.8495310608626e-60!GO:0043283;biopolymer metabolic process;4.49739052995131e-59!GO:0006396;RNA processing;1.63619399876265e-56!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;2.02210724610929e-56!GO:0005840;ribosome;2.83454910429097e-52!GO:0031981;nuclear lumen;3.33978953380337e-50!GO:0006412;translation;8.19352859375743e-50!GO:0031090;organelle membrane;1.42315820198473e-48!GO:0019538;protein metabolic process;2.63108503651445e-45!GO:0003735;structural constituent of ribosome;2.83076722587586e-45!GO:0043234;protein complex;5.84298253266466e-45!GO:0015031;protein transport;3.74898215022392e-44!GO:0033036;macromolecule localization;7.91397855646053e-44!GO:0016043;cellular component organization and biogenesis;1.43779019233633e-43!GO:0044429;mitochondrial part;1.16319985626828e-42!GO:0016071;mRNA metabolic process;9.77013612302025e-42!GO:0044267;cellular protein metabolic process;2.44213500999896e-40!GO:0008380;RNA splicing;6.6522288296567e-40!GO:0044260;cellular macromolecule metabolic process;7.4843235404509e-40!GO:0008104;protein localization;8.06545822413914e-40!GO:0031967;organelle envelope;1.30770788496501e-39!GO:0031975;envelope;3.25472137025811e-39!GO:0003676;nucleic acid binding;3.81789994888084e-39!GO:0044249;cellular biosynthetic process;3.87781869883637e-39!GO:0045184;establishment of protein localization;8.76657588017156e-39!GO:0009058;biosynthetic process;1.19887250962504e-38!GO:0033279;ribosomal subunit;1.9797616091387e-38!GO:0009059;macromolecule biosynthetic process;6.22675251836445e-37!GO:0046907;intracellular transport;4.25925099222145e-36!GO:0006397;mRNA processing;2.85735758261408e-35!GO:0016070;RNA metabolic process;1.67917856841473e-34!GO:0005829;cytosol;4.38546615416267e-34!GO:0022613;ribonucleoprotein complex biogenesis and assembly;5.64534234999374e-34!GO:0043228;non-membrane-bound organelle;1.39211297838337e-32!GO:0043232;intracellular non-membrane-bound organelle;1.39211297838337e-32!GO:0065003;macromolecular complex assembly;8.07666176741161e-32!GO:0006886;intracellular protein transport;2.37624928859474e-30!GO:0005654;nucleoplasm;1.39994921430058e-29!GO:0006996;organelle organization and biogenesis;1.24165740113509e-28!GO:0005681;spliceosome;2.2122637195886e-27!GO:0022607;cellular component assembly;3.59912574523451e-27!GO:0005830;cytosolic ribosome (sensu Eukaryota);1.65816408442918e-26!GO:0005740;mitochondrial envelope;2.06070867493839e-26!GO:0019866;organelle inner membrane;2.3807780957707e-26!GO:0000166;nucleotide binding;6.325965998565e-26!GO:0006259;DNA metabolic process;2.6608460397602e-25!GO:0031966;mitochondrial membrane;1.06613667696344e-24!GO:0005743;mitochondrial inner membrane;1.68029412766754e-24!GO:0044451;nucleoplasm part;1.73271587248127e-23!GO:0005730;nucleolus;4.12637711468173e-23!GO:0051649;establishment of cellular localization;1.51045663719119e-22!GO:0051641;cellular localization;3.69941418702968e-22!GO:0044445;cytosolic part;1.89758850171636e-21!GO:0015935;small ribosomal subunit;5.05622367011357e-21!GO:0012505;endomembrane system;5.40776975360985e-21!GO:0016462;pyrophosphatase activity;5.71592255479866e-21!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;9.17693215253439e-21!GO:0016817;hydrolase activity, acting on acid anhydrides;1.44868871209153e-20!GO:0017111;nucleoside-triphosphatase activity;2.24723523215012e-20!GO:0022618;protein-RNA complex assembly;6.16102626943962e-20!GO:0008134;transcription factor binding;6.60740718843951e-20!GO:0031980;mitochondrial lumen;2.66722436869102e-19!GO:0005759;mitochondrial matrix;2.66722436869102e-19!GO:0006119;oxidative phosphorylation;5.68315972309938e-19!GO:0044265;cellular macromolecule catabolic process;6.6347189078912e-19!GO:0006457;protein folding;1.19368915181966e-18!GO:0015934;large ribosomal subunit;1.58260920846669e-18!GO:0051603;proteolysis involved in cellular protein catabolic process;1.94306959831928e-18!GO:0019941;modification-dependent protein catabolic process;3.65292499358407e-18!GO:0043632;modification-dependent macromolecule catabolic process;3.65292499358407e-18!GO:0044455;mitochondrial membrane part;5.42884655382456e-18!GO:0044257;cellular protein catabolic process;7.34854008010821e-18!GO:0043285;biopolymer catabolic process;7.50047563947979e-18!GO:0006511;ubiquitin-dependent protein catabolic process;9.15683069150845e-18!GO:0007049;cell cycle;1.04865658591469e-17!GO:0016874;ligase activity;1.09101861674046e-17!GO:0032553;ribonucleotide binding;1.49244880801534e-17!GO:0032555;purine ribonucleotide binding;1.49244880801534e-17!GO:0005783;endoplasmic reticulum;1.92195268515204e-17!GO:0048770;pigment granule;6.65998096847805e-17!GO:0042470;melanosome;6.65998096847805e-17!GO:0017076;purine nucleotide binding;1.03166540037626e-16!GO:0009057;macromolecule catabolic process;2.83187985390324e-16!GO:0008135;translation factor activity, nucleic acid binding;8.04341914327707e-16!GO:0006605;protein targeting;8.04341914327707e-16!GO:0006974;response to DNA damage stimulus;8.25448989239745e-16!GO:0044432;endoplasmic reticulum part;9.76116959097697e-16!GO:0000502;proteasome complex (sensu Eukaryota);1.86413973729018e-15!GO:0005761;mitochondrial ribosome;2.07912097562224e-15!GO:0000313;organellar ribosome;2.07912097562224e-15!GO:0030163;protein catabolic process;3.3434874947493e-15!GO:0044248;cellular catabolic process;4.53447902653998e-15!GO:0051082;unfolded protein binding;7.56592058205399e-15!GO:0006512;ubiquitin cycle;9.36105615024309e-15!GO:0042254;ribosome biogenesis and assembly;1.40330907621662e-14!GO:0005746;mitochondrial respiratory chain;1.88863236046824e-14!GO:0000398;nuclear mRNA splicing, via spliceosome;1.95861809381362e-14!GO:0000375;RNA splicing, via transesterification reactions;1.95861809381362e-14!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.95861809381362e-14!GO:0005524;ATP binding;2.25418159946919e-14!GO:0032559;adenyl ribonucleotide binding;3.04461681527162e-14!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);4.59954378163336e-14!GO:0051186;cofactor metabolic process;6.81274489476019e-14!GO:0048193;Golgi vesicle transport;9.59565591990535e-14!GO:0005635;nuclear envelope;1.00164658481355e-13!GO:0050136;NADH dehydrogenase (quinone) activity;1.66721741900029e-13!GO:0003954;NADH dehydrogenase activity;1.66721741900029e-13!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.66721741900029e-13!GO:0006281;DNA repair;1.97261068598897e-13!GO:0031965;nuclear membrane;1.97261068598897e-13!GO:0006913;nucleocytoplasmic transport;2.5370661637008e-13!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;2.67152396600533e-13!GO:0030554;adenyl nucleotide binding;2.79132818288008e-13!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);5.74212721686554e-13!GO:0005794;Golgi apparatus;5.88320539456759e-13!GO:0051169;nuclear transport;6.12583430754157e-13!GO:0016887;ATPase activity;8.71101691722001e-13!GO:0006399;tRNA metabolic process;9.32910528575655e-13!GO:0016604;nuclear body;1.01032437416559e-12!GO:0022402;cell cycle process;1.36385753700516e-12!GO:0042623;ATPase activity, coupled;1.51053385174586e-12!GO:0006446;regulation of translational initiation;2.89254071617216e-12!GO:0050794;regulation of cellular process;3.74268957136274e-12!GO:0006413;translational initiation;3.91804095115466e-12!GO:0043412;biopolymer modification;5.06418668044562e-12!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.90035497438111e-12!GO:0044453;nuclear membrane part;7.35703210576691e-12!GO:0003712;transcription cofactor activity;1.02959797467435e-11!GO:0005789;endoplasmic reticulum membrane;1.26811387147458e-11!GO:0042775;organelle ATP synthesis coupled electron transport;1.56221430655567e-11!GO:0042773;ATP synthesis coupled electron transport;1.56221430655567e-11!GO:0030964;NADH dehydrogenase complex (quinone);2.08168917037596e-11!GO:0045271;respiratory chain complex I;2.08168917037596e-11!GO:0005747;mitochondrial respiratory chain complex I;2.08168917037596e-11!GO:0006732;coenzyme metabolic process;2.95348837031346e-11!GO:0006260;DNA replication;3.41064231403385e-11!GO:0005643;nuclear pore;3.85508440338865e-11!GO:0003743;translation initiation factor activity;5.82871429310273e-11!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.44269863483595e-11!GO:0005694;chromosome;7.05380674958438e-11!GO:0019222;regulation of metabolic process;7.81551214830622e-11!GO:0004386;helicase activity;1.24055735793204e-10!GO:0006403;RNA localization;1.51748909929073e-10!GO:0016192;vesicle-mediated transport;1.84149574554375e-10!GO:0050657;nucleic acid transport;2.0128075033098e-10!GO:0051236;establishment of RNA localization;2.0128075033098e-10!GO:0050658;RNA transport;2.0128075033098e-10!GO:0000278;mitotic cell cycle;2.43326564149296e-10!GO:0006461;protein complex assembly;2.56132132003266e-10!GO:0006464;protein modification process;3.03082248549929e-10!GO:0016607;nuclear speck;3.2350661920696e-10!GO:0009719;response to endogenous stimulus;3.28446682744226e-10!GO:0008026;ATP-dependent helicase activity;3.32131536979869e-10!GO:0051276;chromosome organization and biogenesis;3.85804238142194e-10!GO:0012501;programmed cell death;4.6087219269592e-10!GO:0006364;rRNA processing;6.16966154848708e-10!GO:0008565;protein transporter activity;6.83308870152356e-10!GO:0065002;intracellular protein transport across a membrane;8.08622337191372e-10!GO:0006915;apoptosis;9.49620974195094e-10!GO:0016072;rRNA metabolic process;9.97793050099884e-10!GO:0017038;protein import;1.11481892041735e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.45971672187256e-09!GO:0009055;electron carrier activity;1.74893044120035e-09!GO:0006325;establishment and/or maintenance of chromatin architecture;2.55609783857657e-09!GO:0009056;catabolic process;3.55891482943669e-09!GO:0008639;small protein conjugating enzyme activity;3.81981017496395e-09!GO:0046930;pore complex;4.36210575743566e-09!GO:0043687;post-translational protein modification;4.89647669981933e-09!GO:0016879;ligase activity, forming carbon-nitrogen bonds;5.22766175402804e-09!GO:0004842;ubiquitin-protein ligase activity;6.24040349545905e-09!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;6.38358075374991e-09!GO:0004812;aminoacyl-tRNA ligase activity;6.38358075374991e-09!GO:0016875;ligase activity, forming carbon-oxygen bonds;6.38358075374991e-09!GO:0005793;ER-Golgi intermediate compartment;7.23093926805204e-09!GO:0006323;DNA packaging;7.34446162377611e-09!GO:0044427;chromosomal part;8.8840578522108e-09!GO:0008219;cell death;9.58962260455869e-09!GO:0016265;death;9.58962260455869e-09!GO:0051028;mRNA transport;1.03945575299088e-08!GO:0006366;transcription from RNA polymerase II promoter;1.04392769489028e-08!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;1.14123573490462e-08!GO:0043038;amino acid activation;1.17788012452152e-08!GO:0006418;tRNA aminoacylation for protein translation;1.17788012452152e-08!GO:0043039;tRNA aminoacylation;1.17788012452152e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.51122615709694e-08!GO:0007005;mitochondrion organization and biogenesis;2.1138499934617e-08!GO:0022403;cell cycle phase;2.34727049400444e-08!GO:0006350;transcription;2.42945015131241e-08!GO:0006163;purine nucleotide metabolic process;2.52286205686435e-08!GO:0000087;M phase of mitotic cell cycle;2.54647865965126e-08!GO:0031323;regulation of cellular metabolic process;3.258702136034e-08!GO:0007067;mitosis;3.66068765536947e-08!GO:0019787;small conjugating protein ligase activity;3.77845953165122e-08!GO:0050789;regulation of biological process;4.42418143015472e-08!GO:0043566;structure-specific DNA binding;4.64151260784046e-08!GO:0030532;small nuclear ribonucleoprotein complex;4.88523777486212e-08!GO:0009259;ribonucleotide metabolic process;5.33561814889067e-08!GO:0051188;cofactor biosynthetic process;7.4160679109356e-08!GO:0006164;purine nucleotide biosynthetic process;8.11529740537e-08!GO:0016779;nucleotidyltransferase activity;1.03191266932078e-07!GO:0009150;purine ribonucleotide metabolic process;1.18188816652556e-07!GO:0009141;nucleoside triphosphate metabolic process;1.25438478348048e-07!GO:0051301;cell division;1.27051272860152e-07!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.8100922046153e-07!GO:0005768;endosome;2.23121885290283e-07!GO:0009199;ribonucleoside triphosphate metabolic process;2.55413727958992e-07!GO:0009260;ribonucleotide biosynthetic process;2.73885484955012e-07!GO:0016881;acid-amino acid ligase activity;2.82858538597387e-07!GO:0006888;ER to Golgi vesicle-mediated transport;2.82858538597387e-07!GO:0009142;nucleoside triphosphate biosynthetic process;3.3224717788605e-07!GO:0009201;ribonucleoside triphosphate biosynthetic process;3.3224717788605e-07!GO:0016568;chromatin modification;3.53636053240885e-07!GO:0009152;purine ribonucleotide biosynthetic process;3.72624169851195e-07!GO:0000279;M phase;4.0112194596746e-07!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;4.30209796838652e-07!GO:0016740;transferase activity;4.30209796838652e-07!GO:0000245;spliceosome assembly;4.75295502241444e-07!GO:0010468;regulation of gene expression;4.76065053887532e-07!GO:0000074;regulation of progression through cell cycle;5.00930534631236e-07!GO:0051170;nuclear import;5.40968048199949e-07!GO:0051726;regulation of cell cycle;5.55987243696587e-07!GO:0009205;purine ribonucleoside triphosphate metabolic process;5.56693737541996e-07!GO:0009144;purine nucleoside triphosphate metabolic process;5.56693737541996e-07!GO:0019829;cation-transporting ATPase activity;5.93194386309732e-07!GO:0043067;regulation of programmed cell death;6.21466863668402e-07!GO:0015078;hydrogen ion transmembrane transporter activity;6.4160664904802e-07!GO:0015986;ATP synthesis coupled proton transport;6.85243486327242e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;6.85243486327242e-07!GO:0032446;protein modification by small protein conjugation;7.35353308822676e-07!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;7.48176179920983e-07!GO:0009145;purine nucleoside triphosphate biosynthetic process;7.48176179920983e-07!GO:0042981;regulation of apoptosis;8.42350242969808e-07!GO:0032774;RNA biosynthetic process;8.55859616069034e-07!GO:0003924;GTPase activity;9.00564326987141e-07!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;9.35750778988954e-07!GO:0016567;protein ubiquitination;9.81692444696506e-07!GO:0005667;transcription factor complex;1.02160196052049e-06!GO:0006351;transcription, DNA-dependent;1.03691111119851e-06!GO:0006606;protein import into nucleus;1.18408572684098e-06!GO:0005839;proteasome core complex (sensu Eukaryota);1.3231483320993e-06!GO:0003697;single-stranded DNA binding;1.33709832826061e-06!GO:0009108;coenzyme biosynthetic process;1.54633859685457e-06!GO:0051246;regulation of protein metabolic process;1.57808009571949e-06!GO:0009060;aerobic respiration;1.69973226674128e-06!GO:0045333;cellular respiration;2.45288752604731e-06!GO:0043069;negative regulation of programmed cell death;2.50066337878505e-06!GO:0003713;transcription coactivator activity;2.52856671932469e-06!GO:0065004;protein-DNA complex assembly;2.80938805829648e-06!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;3.07618073913962e-06!GO:0016563;transcription activator activity;3.26261677127549e-06!GO:0015630;microtubule cytoskeleton;3.48694011461667e-06!GO:0003899;DNA-directed RNA polymerase activity;3.94389793394047e-06!GO:0044431;Golgi apparatus part;3.98170740011978e-06!GO:0004298;threonine endopeptidase activity;4.13220169999502e-06!GO:0005770;late endosome;4.30245642513334e-06!GO:0051427;hormone receptor binding;4.72401020136589e-06!GO:0046034;ATP metabolic process;5.46853864735867e-06!GO:0003724;RNA helicase activity;6.10950537018667e-06!GO:0006333;chromatin assembly or disassembly;6.13034495078704e-06!GO:0006754;ATP biosynthetic process;6.58691087914762e-06!GO:0006753;nucleoside phosphate metabolic process;6.58691087914762e-06!GO:0043066;negative regulation of apoptosis;6.77554273962695e-06!GO:0043623;cellular protein complex assembly;7.50190763291974e-06!GO:0031202;RNA splicing factor activity, transesterification mechanism;7.54915187638519e-06!GO:0006752;group transfer coenzyme metabolic process;7.93335678745649e-06!GO:0051168;nuclear export;8.00200876609559e-06!GO:0006613;cotranslational protein targeting to membrane;8.27106786535279e-06!GO:0006261;DNA-dependent DNA replication;8.76805349810742e-06!GO:0016469;proton-transporting two-sector ATPase complex;9.01186759591959e-06!GO:0045259;proton-transporting ATP synthase complex;9.53253235698507e-06!GO:0035257;nuclear hormone receptor binding;1.05279420934034e-05!GO:0030120;vesicle coat;1.14093055097873e-05!GO:0030662;coated vesicle membrane;1.14093055097873e-05!GO:0048475;coated membrane;1.19161249355315e-05!GO:0030117;membrane coat;1.19161249355315e-05!GO:0005525;GTP binding;1.20442687652906e-05!GO:0045454;cell redox homeostasis;1.23786789565655e-05!GO:0000314;organellar small ribosomal subunit;1.49987212827776e-05!GO:0005763;mitochondrial small ribosomal subunit;1.49987212827776e-05!GO:0006916;anti-apoptosis;1.67358079122664e-05!GO:0045449;regulation of transcription;1.90639344232127e-05!GO:0005788;endoplasmic reticulum lumen;1.93167372486416e-05!GO:0003690;double-stranded DNA binding;2.15701428183249e-05!GO:0000785;chromatin;2.33973858131148e-05!GO:0008033;tRNA processing;2.45978576402185e-05!GO:0006793;phosphorus metabolic process;2.72934187926467e-05!GO:0006796;phosphate metabolic process;2.72934187926467e-05!GO:0043021;ribonucleoprotein binding;2.7372939744601e-05!GO:0003714;transcription corepressor activity;2.77815565724618e-05!GO:0044452;nucleolar part;3.03213472056078e-05!GO:0016787;hydrolase activity;3.679508259746e-05!GO:0016491;oxidoreductase activity;3.82017046190459e-05!GO:0009117;nucleotide metabolic process;3.84602945279485e-05!GO:0016564;transcription repressor activity;3.95466497124634e-05!GO:0005762;mitochondrial large ribosomal subunit;4.08784026387284e-05!GO:0000315;organellar large ribosomal subunit;4.08784026387284e-05!GO:0042802;identical protein binding;4.19126155886676e-05!GO:0031988;membrane-bound vesicle;4.36517463439179e-05!GO:0005813;centrosome;4.63445681514135e-05!GO:0015077;monovalent inorganic cation transmembrane transporter activity;5.13061400360735e-05!GO:0016023;cytoplasmic membrane-bound vesicle;6.06728977595165e-05!GO:0005815;microtubule organizing center;6.49793922662137e-05!GO:0006355;regulation of transcription, DNA-dependent;6.62827347499356e-05!GO:0006099;tricarboxylic acid cycle;6.62827347499356e-05!GO:0046356;acetyl-CoA catabolic process;6.62827347499356e-05!GO:0016772;transferase activity, transferring phosphorus-containing groups;6.91306344640505e-05!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;7.14863399356717e-05!GO:0048471;perinuclear region of cytoplasm;7.77983348259996e-05!GO:0008654;phospholipid biosynthetic process;9.75204097847639e-05!GO:0044440;endosomal part;0.000102598589865864!GO:0010008;endosome membrane;0.000102598589865864!GO:0016363;nuclear matrix;0.000102869895116971!GO:0051187;cofactor catabolic process;0.000108018388548003!GO:0006402;mRNA catabolic process;0.00012901144940669!GO:0030867;rough endoplasmic reticulum membrane;0.000138037245039073!GO:0016310;phosphorylation;0.000141865729513703!GO:0031982;vesicle;0.000141984764890375!GO:0006084;acetyl-CoA metabolic process;0.000142703877932312!GO:0006839;mitochondrial transport;0.000146423378383031!GO:0005657;replication fork;0.00014790626634165!GO:0005773;vacuole;0.000158396942715371!GO:0006383;transcription from RNA polymerase III promoter;0.000159390387672642!GO:0007249;I-kappaB kinase/NF-kappaB cascade;0.000165571228462491!GO:0019752;carboxylic acid metabolic process;0.000167183742496159!GO:0000151;ubiquitin ligase complex;0.000169768981198385!GO:0009109;coenzyme catabolic process;0.00017030009489507!GO:0008186;RNA-dependent ATPase activity;0.000173637576003866!GO:0048523;negative regulation of cellular process;0.000176800047195057!GO:0030880;RNA polymerase complex;0.000179004876994121!GO:0006082;organic acid metabolic process;0.000180953630481746!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;0.000187193112473094!GO:0065007;biological regulation;0.000199273670362255!GO:0032561;guanyl ribonucleotide binding;0.000228575418414645!GO:0019001;guanyl nucleotide binding;0.000228575418414645!GO:0031410;cytoplasmic vesicle;0.000232226036538446!GO:0000323;lytic vacuole;0.000252114721169578!GO:0005764;lysosome;0.000252114721169578!GO:0005798;Golgi-associated vesicle;0.000263415433119102!GO:0008250;oligosaccharyl transferase complex;0.000264782419972509!GO:0030176;integral to endoplasmic reticulum membrane;0.000288426746216108!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.000291704358530326!GO:0006414;translational elongation;0.000327430394127392!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000333590362384034!GO:0006401;RNA catabolic process;0.000339171424693616!GO:0051789;response to protein stimulus;0.000351863900271658!GO:0006986;response to unfolded protein;0.000351863900271658!GO:0005048;signal sequence binding;0.000356173271786188!GO:0003729;mRNA binding;0.000377521933874559!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000387189665505585!GO:0006520;amino acid metabolic process;0.000436321794763046!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.000456667044008017!GO:0000428;DNA-directed RNA polymerase complex;0.000456667044008017!GO:0000139;Golgi membrane;0.000479369072484937!GO:0016741;transferase activity, transferring one-carbon groups;0.000500024191029477!GO:0008168;methyltransferase activity;0.000500024191029477!GO:0004004;ATP-dependent RNA helicase activity;0.000514030726973667!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.000514048201271633!GO:0019899;enzyme binding;0.000530251778086353!GO:0033116;ER-Golgi intermediate compartment membrane;0.000601601677079374!GO:0016859;cis-trans isomerase activity;0.000662173827645255!GO:0006612;protein targeting to membrane;0.000670528769030114!GO:0043681;protein import into mitochondrion;0.000697613736385723!GO:0006891;intra-Golgi vesicle-mediated transport;0.00071293858885269!GO:0031324;negative regulation of cellular metabolic process;0.000724105458532579!GO:0000049;tRNA binding;0.000736649519265207!GO:0005819;spindle;0.000736649519265207!GO:0016251;general RNA polymerase II transcription factor activity;0.000755079405535328!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.000883149100172711!GO:0015399;primary active transmembrane transporter activity;0.000883149100172711!GO:0008022;protein C-terminus binding;0.000890521282638395!GO:0005885;Arp2/3 protein complex;0.000916065301474198!GO:0006352;transcription initiation;0.000916676645590172!GO:0004576;oligosaccharyl transferase activity;0.000925209909379835!GO:0018196;peptidyl-asparagine modification;0.000949135891277889!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.000949135891277889!GO:0007264;small GTPase mediated signal transduction;0.000994978310008263!GO:0046483;heterocycle metabolic process;0.00100074329460216!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.0010148673603729!GO:0043161;proteasomal ubiquitin-dependent protein catabolic process;0.00107177844216334!GO:0007051;spindle organization and biogenesis;0.00113656208159983!GO:0003677;DNA binding;0.00116206053332024!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00118761103992911!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00118761103992911!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00118761103992911!GO:0000075;cell cycle checkpoint;0.001224964284973!GO:0008094;DNA-dependent ATPase activity;0.00130345977450919!GO:0030036;actin cytoskeleton organization and biogenesis;0.00130689569728843!GO:0016853;isomerase activity;0.00141475644866904!GO:0000775;chromosome, pericentric region;0.00146088696532292!GO:0051059;NF-kappaB binding;0.00153979714492878!GO:0006302;double-strand break repair;0.00154229158205511!GO:0006626;protein targeting to mitochondrion;0.00159000794152739!GO:0003746;translation elongation factor activity;0.00159094493166121!GO:0006611;protein export from nucleus;0.00160219037637499!GO:0009892;negative regulation of metabolic process;0.00162658992826518!GO:0048500;signal recognition particle;0.00167612230838503!GO:0045786;negative regulation of progression through cell cycle;0.00172394292231501!GO:0000059;protein import into nucleus, docking;0.0017556591175177!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00178470530177764!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.00189549411075641!GO:0015002;heme-copper terminal oxidase activity;0.00189549411075641!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.00189549411075641!GO:0004129;cytochrome-c oxidase activity;0.00189549411075641!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00199196145261292!GO:0048519;negative regulation of biological process;0.00224294786090183!GO:0006091;generation of precursor metabolites and energy;0.00235542061777489!GO:0007010;cytoskeleton organization and biogenesis;0.00259100407497423!GO:0046474;glycerophospholipid biosynthetic process;0.00261644852129911!GO:0031497;chromatin assembly;0.00274818322674174!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00275184648259399!GO:0031252;leading edge;0.00275184648259399!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.00275184648259399!GO:0006334;nucleosome assembly;0.0027574492578163!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0027574492578163!GO:0032508;DNA duplex unwinding;0.00290821762966517!GO:0032392;DNA geometric change;0.00290821762966517!GO:0009165;nucleotide biosynthetic process;0.0029891590429733!GO:0046489;phosphoinositide biosynthetic process;0.00299990627801992!GO:0015980;energy derivation by oxidation of organic compounds;0.00304572288553275!GO:0031072;heat shock protein binding;0.0030506442539617!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00307898040781665!GO:0035258;steroid hormone receptor binding;0.00307898040781665!GO:0051329;interphase of mitotic cell cycle;0.003180437407763!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.00341860554608002!GO:0004674;protein serine/threonine kinase activity;0.0035120066124177!GO:0000776;kinetochore;0.00360352962380885!GO:0003684;damaged DNA binding;0.00363285142297899!GO:0051052;regulation of DNA metabolic process;0.00364432448109296!GO:0008234;cysteine-type peptidase activity;0.00366353025495039!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.00372069846361575!GO:0006405;RNA export from nucleus;0.00413881461598347!GO:0051920;peroxiredoxin activity;0.00419239701302477!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.00419239701302477!GO:0030118;clathrin coat;0.00445359408247087!GO:0031902;late endosome membrane;0.00446861278376143!GO:0007006;mitochondrial membrane organization and biogenesis;0.00454113179401948!GO:0043492;ATPase activity, coupled to movement of substances;0.0046171862481564!GO:0022890;inorganic cation transmembrane transporter activity;0.0046382506715824!GO:0016272;prefoldin complex;0.0046779963245942!GO:0051252;regulation of RNA metabolic process;0.00468363282936536!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00483487592274005!GO:0045047;protein targeting to ER;0.00483487592274005!GO:0030521;androgen receptor signaling pathway;0.00492535613190383!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00494045752875957!GO:0051325;interphase;0.00499920149580733!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.00524887972003048!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.00524887972003048!GO:0006650;glycerophospholipid metabolic process;0.00534181323018059!GO:0005769;early endosome;0.00559532703137903!GO:0016481;negative regulation of transcription;0.00563667078100391!GO:0006338;chromatin remodeling;0.00571490515231845!GO:0030133;transport vesicle;0.00595908440650179!GO:0008139;nuclear localization sequence binding;0.00606546252506747!GO:0043488;regulation of mRNA stability;0.0064299225782449!GO:0043487;regulation of RNA stability;0.0064299225782449!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.0064299225782449!GO:0008312;7S RNA binding;0.00645039136143899!GO:0005905;coated pit;0.00648791291545627!GO:0005665;DNA-directed RNA polymerase II, core complex;0.00704614894113728!GO:0046467;membrane lipid biosynthetic process;0.00722329319717465!GO:0006284;base-excision repair;0.00735436585539596!GO:0006268;DNA unwinding during replication;0.00735820737787037!GO:0000123;histone acetyltransferase complex;0.00748716301914466!GO:0006519;amino acid and derivative metabolic process;0.0076207230164762!GO:0003678;DNA helicase activity;0.0076207230164762!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.00763385458914066!GO:0006749;glutathione metabolic process;0.00763385458914066!GO:0051101;regulation of DNA binding;0.00764161212277057!GO:0030029;actin filament-based process;0.00764695210100159!GO:0051287;NAD binding;0.00767415281694642!GO:0006516;glycoprotein catabolic process;0.00819362582187376!GO:0030659;cytoplasmic vesicle membrane;0.00820850307597845!GO:0000096;sulfur amino acid metabolic process;0.00820850307597845!GO:0006818;hydrogen transport;0.00822206128017982!GO:0015992;proton transport;0.00852963652945995!GO:0043022;ribosome binding;0.00855243906103934!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.00862982373591903!GO:0030132;clathrin coat of coated pit;0.00864916817235993!GO:0005669;transcription factor TFIID complex;0.00890194515408517!GO:0005684;U2-dependent spliceosome;0.00902444218076631!GO:0016044;membrane organization and biogenesis;0.00905610066946483!GO:0003682;chromatin binding;0.00906776348804704!GO:0006984;ER-nuclear signaling pathway;0.00922014453943097!GO:0045045;secretory pathway;0.00924819861529541!GO:0009451;RNA modification;0.00928981062036449!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00946344020667199!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.00949196799228199!GO:0046983;protein dimerization activity;0.00952425080538429!GO:0045893;positive regulation of transcription, DNA-dependent;0.00973879244659754!GO:0016126;sterol biosynthetic process;0.0101721730256424!GO:0051087;chaperone binding;0.0101837854468483!GO:0005741;mitochondrial outer membrane;0.0101990519589951!GO:0031968;organelle outer membrane;0.010561914270243!GO:0043189;H4/H2A histone acetyltransferase complex;0.0106305396502147!GO:0003702;RNA polymerase II transcription factor activity;0.0106638420447931!GO:0006607;NLS-bearing substrate import into nucleus;0.0106967829513318!GO:0005791;rough endoplasmic reticulum;0.0109857582431786!GO:0045941;positive regulation of transcription;0.0118170718237505!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0118258182184067!GO:0048487;beta-tubulin binding;0.0123660828432617!GO:0030134;ER to Golgi transport vesicle;0.012496778669628!GO:0050749;apolipoprotein E receptor binding;0.0125561448312662!GO:0035267;NuA4 histone acetyltransferase complex;0.0131231715000621!GO:0008270;zinc ion binding;0.0131231715000621!GO:0007088;regulation of mitosis;0.0137064942044366!GO:0051540;metal cluster binding;0.0137064942044366!GO:0051536;iron-sulfur cluster binding;0.0137064942044366!GO:0051128;regulation of cellular component organization and biogenesis;0.0139188808296053!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.01406146716838!GO:0030663;COPI coated vesicle membrane;0.0140622242056749!GO:0030126;COPI vesicle coat;0.0140622242056749!GO:0012506;vesicle membrane;0.0141474632786716!GO:0032984;macromolecular complex disassembly;0.0141655286283631!GO:0030658;transport vesicle membrane;0.0143482113214779!GO:0019867;outer membrane;0.0143482113214779!GO:0043284;biopolymer biosynthetic process;0.0144381550438566!GO:0006400;tRNA modification;0.0144675875996006!GO:0000184;mRNA catabolic process, nonsense-mediated decay;0.0146319714482433!GO:0043256;laminin complex;0.0146568110114503!GO:0016197;endosome transport;0.0146662060073129!GO:0044433;cytoplasmic vesicle part;0.0146908897398586!GO:0005832;chaperonin-containing T-complex;0.014779980943697!GO:0031124;mRNA 3'-end processing;0.0148222652716438!GO:0009116;nucleoside metabolic process;0.0150045952636687!GO:0006310;DNA recombination;0.0152652910226771!GO:0005637;nuclear inner membrane;0.0153624293456229!GO:0043596;nuclear replication fork;0.0154290628250331!GO:0008097;5S rRNA binding;0.0158565913870575!GO:0006979;response to oxidative stress;0.0159807451340394!GO:0030131;clathrin adaptor complex;0.0160697243923827!GO:0008538;proteasome activator activity;0.0163401285745203!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;0.016417993240827!GO:0030119;AP-type membrane coat adaptor complex;0.0164391555258078!GO:0033673;negative regulation of kinase activity;0.0165452974522175!GO:0006469;negative regulation of protein kinase activity;0.0165452974522175!GO:0043624;cellular protein complex disassembly;0.0169400996209946!GO:0000792;heterochromatin;0.0175411315272932!GO:0015631;tubulin binding;0.0175411315272932!GO:0006376;mRNA splice site selection;0.0179720367883622!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0179720367883622!GO:0030518;steroid hormone receptor signaling pathway;0.0180007007733322!GO:0019843;rRNA binding;0.0190438242957244!GO:0043241;protein complex disassembly;0.0190438242957244!GO:0007093;mitotic cell cycle checkpoint;0.0193301566965941!GO:0030137;COPI-coated vesicle;0.0194432442818304!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0197179606959178!GO:0022415;viral reproductive process;0.0198415440645945!GO:0003711;transcription elongation regulator activity;0.0198415440645945!GO:0006695;cholesterol biosynthetic process;0.0198415440645945!GO:0047485;protein N-terminus binding;0.0198714498481679!GO:0005802;trans-Golgi network;0.0201942992698687!GO:0006740;NADPH regeneration;0.0202350714636474!GO:0006098;pentose-phosphate shunt;0.0202350714636474!GO:0031625;ubiquitin protein ligase binding;0.020308440443165!GO:0046966;thyroid hormone receptor binding;0.0210281917842072!GO:0030127;COPII vesicle coat;0.0216974519253706!GO:0012507;ER to Golgi transport vesicle membrane;0.0216974519253706!GO:0006506;GPI anchor biosynthetic process;0.0218689421599619!GO:0050662;coenzyme binding;0.0221111390798547!GO:0005874;microtubule;0.0221111390798547!GO:0030384;phosphoinositide metabolic process;0.0221111390798547!GO:0009112;nucleobase metabolic process;0.0224228018598999!GO:0019783;small conjugating protein-specific protease activity;0.0237602284790641!GO:0030660;Golgi-associated vesicle membrane;0.0241691099367314!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0250785779024689!GO:0006144;purine base metabolic process;0.0254450774470454!GO:0005732;small nucleolar ribonucleoprotein complex;0.0256729739180798!GO:0005850;eukaryotic translation initiation factor 2 complex;0.0259176090493809!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;0.0259449848593419!GO:0000226;microtubule cytoskeleton organization and biogenesis;0.026720991873783!GO:0005606;laminin-1 complex;0.027021855981323!GO:0000725;recombinational repair;0.0271499186260544!GO:0000724;double-strand break repair via homologous recombination;0.0271499186260544!GO:0006767;water-soluble vitamin metabolic process;0.0271938279953172!GO:0006417;regulation of translation;0.0276455215790556!GO:0031970;organelle envelope lumen;0.0279426840063455!GO:0006595;polyamine metabolic process;0.0280310172806775!GO:0043621;protein self-association;0.0282580880720928!GO:0051098;regulation of binding;0.0287165419000875!GO:0048037;cofactor binding;0.0287165419000875!GO:0005853;eukaryotic translation elongation factor 1 complex;0.0288834055413239!GO:0004185;serine carboxypeptidase activity;0.0289087046911947!GO:0017166;vinculin binding;0.0289087046911947!GO:0000209;protein polyubiquitination;0.0292666790737675!GO:0006505;GPI anchor metabolic process;0.0295486932558294!GO:0005774;vacuolar membrane;0.0295725073860127!GO:0042158;lipoprotein biosynthetic process;0.0296114032576355!GO:0006497;protein amino acid lipidation;0.0296861433325991!GO:0001836;release of cytochrome c from mitochondria;0.0296861433325991!GO:0008180;signalosome;0.0300012017756984!GO:0007243;protein kinase cascade;0.0301085620681085!GO:0031123;RNA 3'-end processing;0.0303671960345151!GO:0003756;protein disulfide isomerase activity;0.0305419441321161!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0305419441321161!GO:0005784;translocon complex;0.0311313429579391!GO:0007052;mitotic spindle organization and biogenesis;0.0313913603332319!GO:0050681;androgen receptor binding;0.0313957851202123!GO:0006807;nitrogen compound metabolic process;0.0317141543687147!GO:0009308;amine metabolic process;0.0322599103186234!GO:0007030;Golgi organization and biogenesis;0.0326338663339813!GO:0008637;apoptotic mitochondrial changes;0.0329189748467036!GO:0005758;mitochondrial intermembrane space;0.0332726600253794!GO:0004801;transaldolase activity;0.0335594982095943!GO:0016408;C-acyltransferase activity;0.0343950730710301!GO:0004843;ubiquitin-specific protease activity;0.0343950730710301!GO:0051539;4 iron, 4 sulfur cluster binding;0.034411787589647!GO:0008632;apoptotic program;0.0355118695706143!GO:0004197;cysteine-type endopeptidase activity;0.0356909336495359!GO:0030911;TPR domain binding;0.0363397127863638!GO:0051348;negative regulation of transferase activity;0.0363397127863638!GO:0030031;cell projection biogenesis;0.0364702059055138!GO:0007017;microtubule-based process;0.0379268432470297!GO:0048522;positive regulation of cellular process;0.0380981077317992!GO:0000086;G2/M transition of mitotic cell cycle;0.0383242707534817!GO:0006769;nicotinamide metabolic process;0.0387072810454624!GO:0006367;transcription initiation from RNA polymerase II promoter;0.0390875201251282!GO:0019205;nucleobase, nucleoside, nucleotide kinase activity;0.0393822508334373!GO:0051881;regulation of mitochondrial membrane potential;0.0396300613200655!GO:0008092;cytoskeletal protein binding;0.039662670991087!GO:0006672;ceramide metabolic process;0.039764192820735!GO:0046822;regulation of nucleocytoplasmic transport;0.0400428921069376!GO:0005765;lysosomal membrane;0.0402099686012818!GO:0006354;RNA elongation;0.0404230417844793!GO:0015095;magnesium ion transmembrane transporter activity;0.0414327369482719!GO:0007050;cell cycle arrest;0.0414601117598065!GO:0008537;proteasome activator complex;0.0425483694687155!GO:0065009;regulation of a molecular function;0.0426966104744067!GO:0000303;response to superoxide;0.0426966104744067!GO:0043065;positive regulation of apoptosis;0.0426966104744067!GO:0003923;GPI-anchor transamidase activity;0.0427641603897284!GO:0016255;attachment of GPI anchor to protein;0.0427641603897284!GO:0042765;GPI-anchor transamidase complex;0.0427641603897284!GO:0030503;regulation of cell redox homeostasis;0.0429552093451584!GO:0016891;endoribonuclease activity, producing 5'-phosphomonoesters;0.0430918947691232!GO:0008652;amino acid biosynthetic process;0.04368456023748!GO:0004527;exonuclease activity;0.0437868415244707!GO:0022411;cellular component disassembly;0.0439153021903825!GO:0043130;ubiquitin binding;0.0447558167350451!GO:0032182;small conjugating protein binding;0.0447558167350451!GO:0042168;heme metabolic process;0.0448263985241829!GO:0030433;ER-associated protein catabolic process;0.0451087452186202!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0451087452186202!GO:0046519;sphingoid metabolic process;0.0455476099194026!GO:0006778;porphyrin metabolic process;0.0460080923701783!GO:0033013;tetrapyrrole metabolic process;0.0460080923701783!GO:0008757;S-adenosylmethionine-dependent methyltransferase activity;0.0462731062587469!GO:0004221;ubiquitin thiolesterase activity;0.046572438684974!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.0476911340621621!GO:0046914;transition metal ion binding;0.0482056440833736!GO:0000228;nuclear chromosome;0.0490761603030394!GO:0009303;rRNA transcription;0.0495180471800794!GO:0043068;positive regulation of programmed cell death;0.0497686138196941!GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;0.0497686138196941!GO:0004784;superoxide dismutase activity;0.0497686138196941!GO:0040029;regulation of gene expression, epigenetic;0.0499729290894246 | |||
|sample_id=10497 | |||
|sample_note= | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=endometrium | |||
|top_motifs=ADNP_IRX_SIX_ZHX:2.16663155594;SNAI1..3:1.80391977986;HNF1A:1.74224735689;ONECUT1,2:1.67592685731;ZEB1:1.57791447346;ELK1,4_GABP{A,B1}:1.37408278796;PITX1..3:1.33115032621;FOXQ1:1.2628866333;NR6A1:1.24608690638;MYOD1:1.19700713937;DBP:1.17867016532;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.12561946858;ESR1:1.10112638195;IKZF1:1.08286799044;NKX6-1,2:1.07540680339;ZBTB16:1.0419450813;HOX{A6,A7,B6,B7}:1.039259073;NKX2-3_NKX2-5:1.01675170907;STAT1,3:0.997768640154;RBPJ:0.932350481064;bHLH_family:0.928679163368;TBX4,5:0.919192015941;EN1,2:0.891587424118;HOXA9_MEIS1:0.856441437046;CRX:0.840043535287;HOX{A4,D4}:0.83511000054;PPARG:0.83067732979;RORA:0.810368888444;GFI1:0.77093501947;VSX1,2:0.735692064884;STAT5{A,B}:0.714706814226;ESRRA:0.703384202925;FOXN1:0.701062064863;HAND1,2:0.695322848168;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.67095087852;MYB:0.670584339241;PAX4:0.664627020424;FOXP1:0.604038300662;SP1:0.602586131569;FOXA2:0.602548188566;E2F1..5:0.5639685066;NKX3-2:0.544671147788;LHX3,4:0.542469145856;T:0.542348760609;ZNF143:0.51152941136;ZNF148:0.505764802594;PATZ1:0.502246933065;RXRA_VDR{dimer}:0.475487233774;NFY{A,B,C}:0.474075435616;TEF:0.464024371201;FOX{I1,J2}:0.444349562154;NFE2:0.442979023494;POU1F1:0.435102366311;TOPORS:0.420983553791;HBP1_HMGB_SSRP1_UBTF:0.388217802039;CUX2:0.372729463013;MZF1:0.34467995943;LMO2:0.343917323429;TLX1..3_NFIC{dimer}:0.342737174762;OCT4_SOX2{dimer}:0.342421634346;CDC5L:0.342294283184;NFIX:0.336770121361;RXR{A,B,G}:0.335166064196;AIRE:0.335072378656;NFE2L2:0.323273169101;NKX2-1,4:0.318991522586;TEAD1:0.317191797618;NRF1:0.303772967282;IRF7:0.302680727756;RFX1:0.296374144896;ALX4:0.294946207605;PDX1:0.290039049566;CDX1,2,4:0.281642581116;IKZF2:0.247017618686;FOXD3:0.246453979333;LEF1_TCF7_TCF7L1,2:0.240321094158;FOXL1:0.228706433046;EVI1:0.222306234499;ZNF423:0.217338744395;PRRX1,2:0.195875552143;CEBPA,B_DDIT3:0.168257896782;HOX{A5,B5}:0.157103092692;SREBF1,2:0.150909572894;PBX1:0.150540410345;NFKB1_REL_RELA:0.1489298411;POU5F1:0.144937728836;HNF4A_NR2F1,2:0.132134879808;YY1:0.115573812338;RREB1:0.105921729498;NR5A1,2:0.0695607783923;GLI1..3:0.0679216101424;BPTF:0.0485650683974;XBP1:0.0399158548928;HLF:0.0369859058004;SOX17:0.0226531378458;HMGA1,2:0.0177402790242;ARID5B:0.0174379470385;ATF2:0.0116294935949;FOSL2:0.00553410148699;SOX{8,9,10}:0.00221583843897;POU2F1..3:0.000340374063752;NR1H4:-0.0180423577584;FOX{F1,F2,J1}:-0.0244017960216;FOX{D1,D2}:-0.0366451713511;GFI1B:-0.0443810091955;ALX1:-0.079064941019;TP53:-0.104951378987;ELF1,2,4:-0.109166874629;IRF1,2:-0.11559351041;XCPE1{core}:-0.131503789705;RFX2..5_RFXANK_RFXAP:-0.133613460604;STAT2,4,6:-0.134687196666;BACH2:-0.147395786753;FOS_FOS{B,L1}_JUN{B,D}:-0.156348492351;AR:-0.172936850807;KLF4:-0.183430138007;TFCP2:-0.190202976454;GATA6:-0.206078221181;MAZ:-0.210256201167;FOXM1:-0.227765661748;ATF6:-0.255861370256;PAX3,7:-0.258800464793;MED-1{core}:-0.270289685516;TLX2:-0.279271777123;ZFP161:-0.28533045508;ZBTB6:-0.293414989928;REST:-0.305530945987;NR3C1:-0.317747873424;MEF2{A,B,C,D}:-0.324731335714;NFIL3:-0.332882510691;SOX2:-0.360313160394;PAX6:-0.366875171512;GTF2I:-0.369903116883;GTF2A1,2:-0.377318093964;EGR1..3:-0.379721674159;PAX5:-0.386491943037;MYFfamily:-0.386772245878;PAX8:-0.388677068851;SOX5:-0.405187058305;FOXO1,3,4:-0.410050876569;MYBL2:-0.410664658208;NANOG:-0.415681002635;AHR_ARNT_ARNT2:-0.453941495131;ZIC1..3:-0.484142659573;POU3F1..4:-0.496932659726;BREu{core}:-0.503306699888;ATF4:-0.507132782084;ATF5_CREB3:-0.520254062867;ETS1,2:-0.532440340361;DMAP1_NCOR{1,2}_SMARC:-0.536634492265;HIC1:-0.543008844815;EBF1:-0.562523929671;SRF:-0.56448682284;TFAP2{A,C}:-0.567289495273;MTE{core}:-0.573430946837;TFDP1:-0.57527100384;PAX2:-0.591130493316;FOXP3:-0.596283304626;SPI1:-0.603887827371;SPIB:-0.623656534856;TFAP2B:-0.625207693179;TAL1_TCF{3,4,12}:-0.64843460203;POU6F1:-0.652577549168;UFEwm:-0.664760378522;SPZ1:-0.669217625123;MTF1:-0.673588762376;NKX3-1:-0.67394151736;GCM1,2:-0.719911880538;NFE2L1:-0.737035883015;JUN:-0.740008532859;EP300:-0.74355620674;PRDM1:-0.743730974297;NHLH1,2:-0.749660302503;HSF1,2:-0.76583770572;RUNX1..3:-0.870479589471;CREB1:-0.874687613965;ZNF384:-0.892598126465;PAX1,9:-0.894578436575;NANOG{mouse}:-0.914160436794;TBP:-0.97127518261;TGIF1:-1.04784730796;ZNF238:-1.10090948979;HIF1A:-1.11164588745;GZF1:-1.12217569769;HES1:-1.14492249943;NKX2-2,8:-1.1730579574;SMAD1..7,9:-1.27308306471;NFATC1..3:-1.33040038049;MAFB:-1.43619825898;TFAP4:-1.95055574357;GATA4:-2.05966442003;HMX1:-2.10460156596 | |||
|xref= | |||
|zenbu_report=https://fantom.gsc.riken.jp/zenbu/reports/#miRNA_expression_atlas_human;search_select_hide=table111:FF:10497-107C2;search_select_hide=table117:FF:10497-107C2 | |||
}} | }} |
Latest revision as of 14:27, 3 June 2020
Name: | endometrial carcinoma cell line:OMC-2 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | CNhs11266 |
Sample type: | cell lines |
Genomic View: | UCSC |
RefEX: | Specific genes |
CAGEd-oPOSSUM: | link |
ZENBU report : | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
CAGE Accession numbers | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Download raw sequence, BAM & CTSS | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11266
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11266
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.289 |
10 | 10 | 0.948 |
100 | 100 | 0.103 |
101 | 101 | 0.393 |
102 | 102 | 0.397 |
103 | 103 | 0.622 |
104 | 104 | 0.77 |
105 | 105 | 0.363 |
106 | 106 | 0.982 |
107 | 107 | 0.439 |
108 | 108 | 0.934 |
109 | 109 | 0.298 |
11 | 11 | 0.996 |
110 | 110 | 0.233 |
111 | 111 | 0.186 |
112 | 112 | 0.844 |
113 | 113 | 0.256 |
114 | 114 | 0.93 |
115 | 115 | 0.0652 |
116 | 116 | 0.512 |
117 | 117 | 0.011 |
118 | 118 | 0.772 |
119 | 119 | 0.875 |
12 | 12 | 0.244 |
120 | 120 | 0.249 |
121 | 121 | 0.617 |
122 | 122 | 0.312 |
123 | 123 | 0.751 |
124 | 124 | 0.485 |
125 | 125 | 0.169 |
126 | 126 | 0.635 |
127 | 127 | 0.221 |
128 | 128 | 0.258 |
129 | 129 | 0.228 |
13 | 13 | 0.0056 |
130 | 130 | 0.852 |
131 | 131 | 0.509 |
132 | 132 | 0.539 |
133 | 133 | 0.0125 |
134 | 134 | 0.198 |
135 | 135 | 0.00522 |
136 | 136 | 0.07 |
137 | 137 | 0.125 |
138 | 138 | 0.457 |
139 | 139 | 0.514 |
14 | 14 | 0.985 |
140 | 140 | 0.0998 |
141 | 141 | 0.274 |
142 | 142 | 0.915 |
143 | 143 | 0.00132 |
144 | 144 | 0.382 |
145 | 145 | 0.748 |
146 | 146 | 0.777 |
147 | 147 | 0.216 |
148 | 148 | 0.735 |
149 | 149 | 0.339 |
15 | 15 | 0.904 |
150 | 150 | 0.572 |
151 | 151 | 0.992 |
152 | 152 | 0.169 |
153 | 153 | 0.277 |
154 | 154 | 0.0975 |
155 | 155 | 0.915 |
156 | 156 | 0.796 |
157 | 157 | 0.487 |
158 | 158 | 0.651 |
159 | 159 | 0.318 |
16 | 16 | 0.631 |
160 | 160 | 0.402 |
161 | 161 | 0.338 |
162 | 162 | 0.871 |
163 | 163 | 0.996 |
164 | 164 | 0.154 |
165 | 165 | 0.475 |
166 | 166 | 0.693 |
167 | 167 | 0.87 |
168 | 168 | 0.462 |
169 | 169 | 0.0705 |
17 | 17 | 0.448 |
18 | 18 | 0.29 |
19 | 19 | 0.92 |
2 | 2 | 0.367 |
20 | 20 | 0.158 |
21 | 21 | 0.877 |
22 | 22 | 0.967 |
23 | 23 | 0.532 |
24 | 24 | 0.271 |
25 | 25 | 0.491 |
26 | 26 | 0.931 |
27 | 27 | 0.351 |
28 | 28 | 0.297 |
29 | 29 | 0.887 |
3 | 3 | 0.567 |
30 | 30 | 0.172 |
31 | 31 | 0.896 |
32 | 32 | 0.0807 |
33 | 33 | 0.227 |
34 | 34 | 0.883 |
35 | 35 | 0.971 |
36 | 36 | 0.489 |
37 | 37 | 0.137 |
38 | 38 | 0.582 |
39 | 39 | 0.84 |
4 | 4 | 0.995 |
40 | 40 | 0.383 |
41 | 41 | 0.00161 |
42 | 42 | 0.56 |
43 | 43 | 0.996 |
44 | 44 | 0.727 |
45 | 45 | 0.243 |
46 | 46 | 0.995 |
47 | 47 | 0.258 |
48 | 48 | 0.512 |
49 | 49 | 0.779 |
5 | 5 | 0.824 |
50 | 50 | 0.203 |
51 | 51 | 0.803 |
52 | 52 | 0.645 |
53 | 53 | 0.828 |
54 | 54 | 0.886 |
55 | 55 | 0.928 |
56 | 56 | 0.526 |
57 | 57 | 0.324 |
58 | 58 | 0.589 |
59 | 59 | 0.542 |
6 | 6 | 0.764 |
60 | 60 | 0.458 |
61 | 61 | 0.0411 |
62 | 62 | 0.236 |
63 | 63 | 0.453 |
64 | 64 | 0.966 |
65 | 65 | 0.69 |
66 | 66 | 0.263 |
67 | 67 | 0.403 |
68 | 68 | 0.043 |
69 | 69 | 0.395 |
7 | 7 | 0.781 |
70 | 70 | 0.851 |
71 | 71 | 0.183 |
72 | 72 | 0.912 |
73 | 73 | 0.46 |
74 | 74 | 0.148 |
75 | 75 | 0.0347 |
76 | 76 | 0.88 |
77 | 77 | 0.196 |
78 | 78 | 0.776 |
79 | 79 | 0.00252 |
8 | 8 | 0.505 |
80 | 80 | 0.229 |
81 | 81 | 0.0346 |
82 | 82 | 0.201 |
83 | 83 | 0.334 |
84 | 84 | 0.274 |
85 | 85 | 0.259 |
86 | 86 | 0.471 |
87 | 87 | 0.0192 |
88 | 88 | 0.0352 |
89 | 89 | 0.62 |
9 | 9 | 0.403 |
90 | 90 | 0.178 |
91 | 91 | 0.268 |
92 | 92 | 0.783 |
93 | 93 | 0.58 |
94 | 94 | 0.136 |
95 | 95 | 0.172 |
96 | 96 | 0.23 |
97 | 97 | 0.765 |
98 | 98 | 0.849 |
99 | 99 | 0.85 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11266
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000210 human sample
FF:0100167 adenocarcinoma cell line sample
FF:0101555 endometrial cancer cell line sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000548 (animal cell)
0002320 (connective tissue cell)
0000066 (epithelial cell)
0002371 (somatic cell)
0000499 (stromal cell)
0000255 (eukaryotic cell)
0002076 (endo-epithelial cell)
0002149 (epithelial cell of uterus)
0002255 (stromal cell of endometrium)
DOID: Disease
4 (disease)
0050686 (organ system cancer)
162 (cancer)
14566 (disease of cellular proliferation)
0050687 (cell type cancer)
193 (reproductive organ cancer)
305 (carcinoma)
120 (female reproductive organ cancer)
299 (adenocarcinoma)
3001 (female reproductive endometrioid cancer)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000995 (uterus)
0002384 (connective tissue)
0003134 (female reproductive organ)
0000479 (tissue)
0005156 (reproductive structure)
0000062 (organ)
0004120 (mesoderm-derived structure)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000990 (reproductive system)
0000467 (anatomical system)
0001062 (anatomical entity)
0000480 (anatomical group)
0003133 (reproductive organ)
0003975 (internal female genitalia)
0004175 (internal genitalia)
0010317 (germ layer / neural crest derived structure)
0003100 (female organism)
0000474 (female reproductive system)
FF: FANTOM5
0000102 (sample by type)
0000003 (cell line sample)
0000210 (human sample)
0000101 (sample by species)
0000001 (sample)
0100297 (carcinoma cell line sample)
0101120 (epithelial cell line sample)
0100167 (adenocarcinoma cell line sample)
0101555 (endometrial cancer cell line sample)
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
CL:0000134 (mesenchymal cell)
CL:0000223 (endodermal cell)
UBERON:0002532 (epiblast (generic))
UBERON:0006603 (presumptive mesoderm)
UBERON:0010316 (germ layer / neural crest)